US5120640A
(en)
|
1981-05-15 |
1992-06-09 |
Chaya Moroz |
Placental isoferritins for the prognosis and diagnosis of immunosuppression
|
US5173400A
(en)
|
1983-09-15 |
1992-12-22 |
Institut Pasteur |
Antibody detection of antibodies to viral proteins in serum
|
US6428952B1
(en)
|
1983-09-15 |
2002-08-06 |
Institut Pasteur |
Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies
|
US5135864A
(en)
|
1983-09-15 |
1992-08-04 |
Institut Pasteur |
Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor
|
US6600023B1
(en)
|
1983-09-15 |
2003-07-29 |
Institut Pasteur |
Antibody directed against HIV-1 P25 antigen
|
US5217861A
(en)
|
1983-09-15 |
1993-06-08 |
Institut Pasteur |
Antigen of a human retrovirus, namely p18 protein of human immunodeficiency virus (HIV), compositions containing the antigen, a diagnostic method for detecting acquired immune deficiency syndrome (AIDS) and pre-AIDS and a kit therefor
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US5374519A
(en)
|
1983-12-05 |
1994-12-20 |
Institut Pasteur |
Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS)
|
US5843638A
(en)
|
1983-12-05 |
1998-12-01 |
Institut Pasteur And Centre National De La Recherche Scientifique |
Nucleic acids and pepties of human immunodeficiency virus type-1 (HIV-1).
|
US5610035A
(en)
|
1983-12-05 |
1997-03-11 |
Institut Pasteur Centre National De La Recherche Scientific |
Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
|
US5762965A
(en)
|
1984-03-16 |
1998-06-09 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
|
EP0162738A1
(en)
|
1984-04-09 |
1985-11-27 |
MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP |
Production of pseudorabies virus subunit vaccines
|
US6610476B1
(en)
|
1984-08-22 |
2003-08-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Detection of HIV-1 DNA
|
US7045130B1
(en)
|
1984-10-18 |
2006-05-16 |
Institut Pasteur |
Antibodies against antigens of human immunodeficiency virus (HIV-1)
|
US5705612A
(en)
|
1984-10-18 |
1998-01-06 |
Institut Pasteur And Centre National De La Recherche Scientifique |
NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)
|
US5980900A
(en)
|
1984-10-18 |
1999-11-09 |
Institut Pasteur And Centre National De La Recherche Scientifique |
Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
US7285271B1
(en)
|
1984-10-31 |
2007-10-23 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenic composition comprising an HIV gag or env polypeptide
|
US7393949B1
(en)
|
1987-12-24 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Human immunodeficiency virus (HIV) nucleotide sequences
|
US7273695B1
(en)
|
1984-10-31 |
2007-09-25 |
Novartis Vaccines And Diagnostics, Inc. |
HIV immunoassays using synthetic envelope polypeptides
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
FR2580177B2
(fr)
|
1985-04-15 |
1989-06-02 |
Pasteur Institut |
Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
|
US5801056A
(en)
|
1985-05-24 |
1998-09-01 |
Dana-Farber Cancer Institute |
Nucleic acid encoding HIV-1 tat protein
|
US6074650A
(en)
|
1985-06-24 |
2000-06-13 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
US4945082A
(en)
|
1985-08-26 |
1990-07-31 |
Hem Research, Inc. |
Controlled dsRNA therapy for human viral infections
|
US5068174A
(en)
|
1985-11-07 |
1991-11-26 |
President And Fellows Of Harvard College |
T-cell lymphotrophic virus protein and assay
|
EP0249611A4
(en)
|
1985-11-14 |
1988-04-26 |
Harvard College |
T-LYMPHOTROPHIC VIRUS.
|
CS256960B1
(en)
|
1985-11-16 |
1988-04-15 |
Viktor Krchnak |
Peptides with properties of antigenic determinants and method of their production
|
FR2590674B1
(fr)
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
WO1987003903A1
(en)
|
1985-12-23 |
1987-07-02 |
Fred Hutchinson Cancer Research Center |
Regulating retroviral replication, infection, and pathogenesis
|
US6037165A
(en)
|
1986-01-22 |
2000-03-14 |
Institut Pasteur |
Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby
|
US5858651A
(en)
|
1986-01-22 |
1999-01-12 |
Institut Pasteur |
Nucleotide sequences of human immunodeficiency virus type 2 (HIV-2), probes of HIV-2, and methods of using these probes
|
US4839288A
(en)
|
1986-01-22 |
1989-06-13 |
Institut Pasteur |
Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
|
US6514691B1
(en)
|
1986-01-22 |
2003-02-04 |
Institut Pasteur |
Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
|
US5364933A
(en)
|
1986-03-03 |
1994-11-15 |
Institut Pasteur |
Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
|
US5830641A
(en)
|
1986-01-22 |
1998-11-03 |
Institut Pasteur |
In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies
|
US5310651A
(en)
|
1986-01-22 |
1994-05-10 |
Institut Pasteur |
DNA probes of human immunodeficiency virus type 2 (HIV-2), and methods employing these probes for dectecting the presence of HIV-2
|
US5976785A
(en)
|
1986-01-22 |
1999-11-02 |
Institut Pasteur |
Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
|
KR910002428B1
(ko)
|
1986-01-22 |
1991-04-22 |
엥스뛰띠 파스떼르 |
Aids를 유발시킬수 있는 신규 레트로비루스의 제조방법
|
US5066782A
(en)
|
1986-01-22 |
1991-11-19 |
Institut Pasteur |
Retrovirus capable of causing AIDS, means and method for detecting it in vitro
|
US5268265A
(en)
|
1986-01-22 |
1993-12-07 |
Institut Pasteur |
Immunological complex comprising an antigen of Simian Immunodeficiency Virus (SIV) and an antibody against human immunodeficiency virus type 2 (HIV 2), and method and kit for detecting antibodies to HIV-2 reactive with antigens of SIV
|
US5580739A
(en)
|
1986-01-22 |
1996-12-03 |
Institut Pasteur |
Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
|
US5468606A
(en)
|
1989-09-18 |
1995-11-21 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
US6054565A
(en)
|
1986-03-03 |
2000-04-25 |
Institut Pasteur |
Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2
|
US4983387A
(en)
|
1986-05-19 |
1991-01-08 |
Viral Technologies Inc. |
HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
|
US5276016A
(en)
|
1986-06-03 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Small peptides which inhibit binding to T-4 receptors and act as immunogens
|
US5034511A
(en)
|
1987-04-13 |
1991-07-23 |
Institut Pasteur |
Variant of LAV viruses
|
US5824482A
(en)
|
1986-06-23 |
1998-10-20 |
Institut Pasteur |
Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
|
US5166050A
(en)
|
1986-08-20 |
1992-11-24 |
Bristol-Myers Squibb Company |
Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
|
EP0261940A3
(en)
|
1986-09-23 |
1989-07-05 |
Applied Biotechnology, Inc. |
Pseudorabies vaccines and dna vectors for recombination with pox viruses
|
IE872748L
(en)
|
1986-10-16 |
1988-04-16 |
Arjomari Europ |
Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
|
US5206136A
(en)
|
1986-11-19 |
1993-04-27 |
Genetic Systems Corporation |
Rapid membrane affinity concentration assays
|
US6294322B1
(en)
|
1988-01-26 |
2001-09-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1
|
US5939074A
(en)
|
1986-12-30 |
1999-08-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Multideterminant peptide antigens
|
US5030449A
(en)
|
1988-07-21 |
1991-07-09 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Synthetic vaccine against AIDS virus
|
US6322964B1
(en)
|
1987-01-16 |
2001-11-27 |
Genetic Systems Corporation |
Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies
|
US4861707A
(en)
|
1987-02-02 |
1989-08-29 |
E. I. Du Pont De Nemours And Company |
Human immunodeficiency virus antigen
|
US5140105A
(en)
|
1987-02-19 |
1992-08-18 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
US5169752A
(en)
|
1987-02-19 |
1992-12-08 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
US5180660A
(en)
|
1987-02-19 |
1993-01-19 |
Nissin Shokuhin Kabushiki Kaisha |
Methods and materials for HIV detection
|
US5217895A
(en)
|
1987-02-19 |
1993-06-08 |
Nissin Shokuhin Kabushiki Kaisha |
Monoclonal anti-idiotypic antibodies specific for anti-T4 antibodies and cross-reactive with HIV
|
US4942122A
(en)
|
1987-02-24 |
1990-07-17 |
Research Education Institute, Inc. |
Aids prognosis test detecting the presence of antibodies inhibiting HIV reverse transcriptase
|
US4997772A
(en)
|
1987-09-18 |
1991-03-05 |
Eastman Kodak Company |
Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
|
US5591632A
(en)
|
1987-03-02 |
1997-01-07 |
Beth Israel Hospital |
Recombinant BCG
|
US6812024B2
(en)
|
1987-03-16 |
2004-11-02 |
Mcgready Roland Keith |
Anti-paratopic antibody as an immunogen
|
US4918166A
(en)
|
1987-04-10 |
1990-04-17 |
Oxford Gene Systems Limited |
Particulate hybrid HIV antigens
|
US5122446A
(en)
|
1987-04-17 |
1992-06-16 |
New York University |
Method for detecting antibodies to human immunodeficiency virus
|
US5100777A
(en)
|
1987-04-27 |
1992-03-31 |
Tanox Biosystems, Inc. |
Antibody matrix device and method for evaluating immune status
|
US5104790A
(en)
|
1987-06-29 |
1992-04-14 |
Genetic Systems Corporation |
Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
|
US4921787A
(en)
|
1987-05-01 |
1990-05-01 |
Cambridge Bioscience Corporation |
Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US5854400A
(en)
|
1987-05-29 |
1998-12-29 |
Tanox, Inc. |
Monoclonal antibodies which neutralize HIV-1 infection
|
US4795739A
(en)
|
1987-05-29 |
1989-01-03 |
Gene Labs, Inc. |
Method of inhibiting HIV
|
US5981278A
(en)
|
1987-05-29 |
1999-11-09 |
Tanox, Inc. |
Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
|
US4869903A
(en)
|
1987-05-29 |
1989-09-26 |
Genelabs Incorporated |
Method of selectively inhibiting HIV
|
US5591829A
(en)
|
1987-05-29 |
1997-01-07 |
Matsushita; Shuzo |
Antibodies modified with toxic substance
|
US5834599A
(en)
|
1987-05-29 |
1998-11-10 |
Tanox Biosystems, Inc. |
Immunoconjugates which neutralize HIV-1 infection
|
US6657050B1
(en)
|
1987-05-29 |
2003-12-02 |
Tanox, Inc. |
Chimeric viral-neutralizing immunoglobulins
|
EP0295803B1
(en)
|
1987-05-29 |
1993-11-03 |
Shuzo Matsushita |
Monoclonal antibodies
|
US5256767A
(en)
|
1987-06-10 |
1993-10-26 |
The Immune Response Corporation |
Retroviral antigens
|
US4886742A
(en)
|
1987-06-15 |
1989-12-12 |
Coulter Corporation |
Enzyme immunoassay for detecting HIV antigens in human sera
|
US4870003A
(en)
|
1987-06-15 |
1989-09-26 |
Coulter Corporation |
Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
|
DE3853139T2
(de)
|
1987-06-26 |
1995-06-14 |
Syntro Corp |
Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
|
US5273876A
(en)
|
1987-06-26 |
1993-12-28 |
Syntro Corporation |
Recombinant human cytomegalovirus containing foreign gene
|
DK362287D0
(da)
|
1987-07-13 |
1987-07-13 |
Kurt Baekgaard Osther |
Method for rapid and sensitive detection of hiv-1 antibodies
|
EP0324849B1
(en)
|
1987-07-13 |
1995-10-04 |
Verigen, Inc. |
Method for rapid and sensitive detection of IgM antibodies to retroviral antigens
|
US5637677A
(en)
|
1987-07-16 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Biologically active compounds and methods of constructing and using the same
|
US5447837A
(en)
|
1987-08-05 |
1995-09-05 |
Calypte, Inc. |
Multi-immunoassay diagnostic system for antigens or antibodies or both
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US5554528A
(en)
|
1987-08-21 |
1996-09-10 |
Board Of Revents Of University Of Colorado |
Compositions and methods for inhibition of HIV production
|
US5039604A
(en)
|
1987-08-21 |
1991-08-13 |
Cellular Products, Inc. |
Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
|
US5585254A
(en)
|
1987-08-21 |
1996-12-17 |
University Of Colorado Foundation, Inc. |
Autonomous parvovirus gene delivery vehicles and expression vectors
|
US6210873B1
(en)
|
1987-08-28 |
2001-04-03 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
|
IL83687A
(en)
|
1987-08-30 |
1995-03-30 |
Yeda Res & Dev |
Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
|
US5019387A
(en)
|
1987-09-08 |
1991-05-28 |
Duke University |
Production of antibodies to HIV
|
US5993819A
(en)
|
1987-09-08 |
1999-11-30 |
Duke University |
Synthetic vaccine for protection against human immunodeficiency virus infection
|
US5397695A
(en)
|
1987-09-18 |
1995-03-14 |
Eastman Kodak Company |
Attachment of compounds to polymeric particles using carbamoylonium compounds and a kit containing same
|
US5571667A
(en)
|
1987-10-01 |
1996-11-05 |
Chu; Albert E. |
Elongated membrane flow-through diagnostic device and method
|
SE8704185L
(sv)
|
1987-10-28 |
1989-04-29 |
Ferring Ab |
Nya peptider, artificiella antigener och immunoanalystestsatser
|
US4888290A
(en)
|
1987-11-06 |
1989-12-19 |
Coulter Corporation |
Monoclonal antibody specific to HIV antigens
|
EP0355140B1
(en)
|
1987-11-13 |
1996-03-20 |
KATINGER, Hermann |
Human monoclonal anti-hiv-i-antibodies
|
US4900548A
(en)
|
1987-11-13 |
1990-02-13 |
Harvard University |
Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
|
US5831034A
(en)
|
1987-11-13 |
1998-11-03 |
Hermann Katinger |
Human monoclonal anti-HIV-I-antibodies
|
US5780038A
(en)
|
1987-11-16 |
1998-07-14 |
Roche Diagnostic Systems, Inc. |
HIV-2 envelope polypeptides
|
US5215913A
(en)
|
1987-11-30 |
1993-06-01 |
Roger Williams General Hospital |
IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
|
GB2213057A
(en)
|
1987-12-08 |
1989-08-09 |
I Pascuchi Josep Maria Vich |
Anti-viral agent
|
CA1312277C
(en)
|
1987-12-18 |
1993-01-05 |
Richard C. Sutton |
Avidin- and biotin-immobilized reagents, analytical elements and methods of use
|
US6004781A
(en)
|
1988-01-22 |
1999-12-21 |
The General Hospital Corporation |
Nucleic acid encoding Ig-CD4 fusion proteins
|
US5039522A
(en)
|
1988-01-29 |
1991-08-13 |
New York Blood Center, Inc. |
Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen
|
US5716826A
(en)
|
1988-03-21 |
1998-02-10 |
Chiron Viagene, Inc. |
Recombinant retroviruses
|
US6133029A
(en)
|
1988-03-21 |
2000-10-17 |
Chiron Corporation |
Replication defective viral vectors for infecting human cells
|
AU3342689A
(en)
|
1988-03-24 |
1989-10-16 |
Igen Incorporated |
Luminescent chimeric proteins
|
CA1340982C
(en)
|
1988-03-25 |
2000-05-02 |
Toby C. Rodman |
Protamine-reactive igm antibodies
|
US5606026A
(en)
|
1988-03-25 |
1997-02-25 |
The Institute For Human Genetics And Biochemistry |
Natural human IgM antibodies immunoreactive with the Tat protein of HIV-1
|
US5695927A
(en)
|
1988-03-31 |
1997-12-09 |
The University Of Arizona, Department Of Internal Medicine, Section Of Hematology And Oncology |
Monoclonal antibodies specific for HIV and the hybridomas for production thereof
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
US5204259A
(en)
|
1988-05-06 |
1993-04-20 |
Pharmacia Genetic Engineering, Inc. |
Methods and systems for producing HIV antigens
|
US5008183A
(en)
|
1988-05-10 |
1991-04-16 |
Bio-Research Laboratories, Inc. |
Assay system for detecting antibody and a method of producing non-human immune antibody
|
US5264342A
(en)
|
1988-05-10 |
1993-11-23 |
Verigen, Inc. |
Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
|
US5043262A
(en)
|
1988-05-12 |
1991-08-27 |
Dana Farber Cancer Institute |
Protein, sequences containing the VPU gene therefore, vectors, methods of preparation and use
|
US5221610A
(en)
|
1988-05-26 |
1993-06-22 |
Institut Pasteur |
Diagnostic method and composition for early detection of HIV infection
|
US5212084A
(en)
|
1988-06-01 |
1993-05-18 |
Emory University |
Retrovirus and related method used for producing a model for evaluating the antiretroviral effects of drugs and vaccines
|
EP0657532B1
(en)
|
1988-06-09 |
2003-12-17 |
N.V. Innogenetics S.A. |
HIV-3 retrovirus strains and their use
|
US5312902A
(en)
|
1988-06-09 |
1994-05-17 |
Institut Pasteur |
Dimer of the precursor of HIV-2 envelope glycoprotein
|
US5208321A
(en)
|
1988-06-09 |
1993-05-04 |
Institut Pasteur |
HIV-2 transmembrane glycoprotein homodimer (GP 80)
|
US6197496B1
(en)
|
1988-06-09 |
2001-03-06 |
Institut Pasteur |
Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80
|
US5631154A
(en)
|
1988-06-10 |
1997-05-20 |
Therion Biologics, Incorporated |
Self assembled, defective, non-self-propagating lentivirus particles
|
US5747324A
(en)
|
1988-06-10 |
1998-05-05 |
Therion Biologics Corporation |
Self-assembled, defective, non-self-propagating lentivirus particles
|
US5173399A
(en)
|
1988-06-10 |
1992-12-22 |
Abbott Laboratories |
Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
|
US4983529A
(en)
|
1988-06-10 |
1991-01-08 |
Abbott Laboratories |
Immunoassay for HIV-I antigens using F(AB')2 fragments as probe
|
ATE241014T2
(de)
|
1988-06-14 |
2003-06-15 |
Qiagen Gmbh |
Hiv-2 varianten
|
US5286852A
(en)
|
1988-07-06 |
1994-02-15 |
Verigen, Inc. |
Antibodies specific towards HIV-1 gp 48
|
US5658569A
(en)
|
1988-07-06 |
1997-08-19 |
Verigen, Inc. |
Anti-HIV-1 neutralizing antibodies
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
US5185147A
(en)
|
1988-08-19 |
1993-02-09 |
Cellular Products, Inc. |
Short polypeptide sequences useful in the production and detection of antibodies against human immunodeficiency virus
|
IE882585L
(en)
|
1988-08-25 |
1990-02-25 |
Prendergast Patrick T |
Viral treatment system
|
US5030555A
(en)
|
1988-09-12 |
1991-07-09 |
University Of Florida |
Membrane-strip reagent serodiagnostic apparatus and method
|
US5866701A
(en)
|
1988-09-20 |
1999-02-02 |
The Board Of Regents For Northern Illinois University Of Dekalb |
HIV targeted hairpin ribozymes
|
US5183949A
(en)
|
1988-09-22 |
1993-02-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Rabbit model for diagnosing and testing vaccines or therapeutic agents against aids
|
ATE118247T1
(de)
|
1988-09-27 |
1995-02-15 |
Dana Farber Cancer Inst Inc |
Vektor, der ein replikationskompetentes hiv-i- provirus und ein heterologes gen enthält.
|
US5077192A
(en)
|
1988-10-25 |
1991-12-31 |
The General Hospital Corporation |
Method of detecting antigenic, nucleic acid-containing macromolecular entities
|
US5916563A
(en)
|
1988-11-14 |
1999-06-29 |
United States Of America |
Parvovirus protein presenting capsids
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
CA2003383A1
(en)
|
1988-11-23 |
1990-05-23 |
Sushil G. Devare |
Synthetic dna derived recombinant hiv antigens
|
US5604092A
(en)
|
1988-12-05 |
1997-02-18 |
The Trustees Of Columbia University In The City Of New York |
Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein
|
US4906476A
(en)
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US6306625B1
(en)
|
1988-12-30 |
2001-10-23 |
Smithkline Beecham Biologicals, Sa |
Method for obtaining expression of mixed polypeptide particles in yeast
|
US5077284A
(en)
|
1988-12-30 |
1991-12-31 |
Loria Roger M |
Use of dehydroepiandrosterone to improve immune response
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
US5254457A
(en)
|
1989-01-11 |
1993-10-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Monoclonal antibodies and method for identifying different aids-related viruses
|
DE69032841T2
(de)
|
1989-01-23 |
1999-05-12 |
Chiron Corp., Emeryville, Calif. |
Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
|
US5227159A
(en)
|
1989-01-31 |
1993-07-13 |
Miller Richard A |
Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
|
ATE113989T1
(de)
|
1989-02-03 |
1994-11-15 |
Abbott Lab |
Monoklonaler antikörper zur unterscheidung hiv-2- seropositiver von hiv-1-seropositiven individuen.
|
US5665577A
(en)
|
1989-02-06 |
1997-09-09 |
Dana-Farber Cancer Institute |
Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
|
WO1990010230A1
(en)
|
1989-02-23 |
1990-09-07 |
University Of Ottawa |
Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
|
US5731189A
(en)
|
1989-02-28 |
1998-03-24 |
New York University |
Human monoclonal antibodies to human immunodeficiency virus
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5223423A
(en)
|
1989-03-31 |
1993-06-29 |
United States Of America |
Characterization of replication competent human immunodeficiency type 2 proviral clone hiv-2sbl/isy
|
US6309880B1
(en)
|
1989-04-25 |
2001-10-30 |
Tanox, Inc. |
Antibodies specific for CD4-binding domain of HIV-1
|
JP3124018B2
(ja)
|
1989-05-02 |
2001-01-15 |
アボット・ラボラトリーズ |
結合アッセイ用固相の調製方法
|
US5817318A
(en)
|
1989-05-03 |
1998-10-06 |
Connaught Laboratories Limited |
Synthetic peptides for an HIV-1 vaccine
|
US5120662A
(en)
|
1989-05-09 |
1992-06-09 |
Abbott Laboratories |
Multilayer solid phase immunoassay support and method of use
|
AU637097B2
(en)
|
1989-05-09 |
1993-05-20 |
Abbott Laboratories |
Process for preparing an improved western blot immunoassay
|
US5210181A
(en)
|
1989-05-15 |
1993-05-11 |
Akzo N.V. |
T-lymphotropic retrovirus peptide
|
DE3916251C1
(lt)
|
1989-05-18 |
1991-01-03 |
Gesellschaft Fuer Strahlen- Und Umweltforschung Mbh (Gsf), 8000 Muenchen, De |
|
US5320940A
(en)
|
1989-05-19 |
1994-06-14 |
Board Of Regents, The University Of Texas System |
Methods and compositions for identifying and characterizing individuals having autoimmune rheumatic diseases
|
US5439792A
(en)
|
1989-06-02 |
1995-08-08 |
Genetic Systems Corporation |
Cysteine thiol-protected peptides for use in immunoassays
|
DE69033311T2
(de)
|
1989-06-02 |
2000-02-17 |
Institut National De La Sante Et De La Recherche Medicale I.N.S.E.R.M., Paris |
Nukleotid-Sequenzen des Genoms von Retroviren vom Typ HIV-1, HIV-2 und SIV, ihre Verwendungen zur Amplifikation dieser Genome und in-vitro-Diagnose dieser viralen Infektionen
|
FR2647810B1
(fr)
|
1989-06-02 |
1994-07-22 |
Pasteur Institut |
Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
|
US7022814B1
(en)
|
1992-01-21 |
2006-04-04 |
Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale |
Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
|
DK0431129T3
(da)
|
1989-06-15 |
1996-06-17 |
Rorer Int Overseas |
Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
|
US5144019A
(en)
|
1989-06-21 |
1992-09-01 |
City Of Hope |
Ribozyme cleavage of HIV-I RNA
|
US5156951A
(en)
|
1989-07-13 |
1992-10-20 |
Becton Dickinson And Company |
Detecting immunological changes in HIV infected patient samples
|
US6080846A
(en)
|
1989-08-18 |
2000-06-27 |
Institut Pasteur |
Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
|
US5688914A
(en)
|
1989-08-18 |
1997-11-18 |
Institut Pasteur |
Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
|
US5100662A
(en)
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
US6008044A
(en)
|
1989-08-24 |
1999-12-28 |
Bioclonetics |
Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
|
US5541057A
(en)
|
1989-09-18 |
1996-07-30 |
Biostar, Inc. |
Methods for detection of an analyte
|
US5103836A
(en)
|
1990-02-28 |
1992-04-14 |
Epitope, Inc. |
Oral collection device and kit for immunoassay
|
US5335673A
(en)
|
1989-09-21 |
1994-08-09 |
Epitope, Inc. |
Oral collection device and method for immunoassay
|
US5225347A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Therapeutic ribozyme compositions and expression vectors
|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
DE3934366A1
(de)
|
1989-10-14 |
1991-04-18 |
Chemotherapeutisches Forschungsinstitut Georg Speyer Haus |
Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum
|
US5861282A
(en)
|
1989-10-16 |
1999-01-19 |
Whitehead Institute For Biomedical Research |
Non-infectious HIV particles and uses therefor
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5070010A
(en)
|
1989-10-30 |
1991-12-03 |
Hoffman-La Roche Inc. |
Method for determining anti-viral transactivating activity
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
EP0510054A1
(en)
|
1990-01-05 |
1992-10-28 |
United Biomedical, Inc. |
Hiv-1 core protein fragments
|
US5629153A
(en)
|
1990-01-10 |
1997-05-13 |
Chiron Corporation |
Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
|
US5849288A
(en)
|
1990-01-15 |
1998-12-15 |
Yeda Research And Development Co. Ltd. |
Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
|
US5652373A
(en)
|
1990-01-15 |
1997-07-29 |
Yeda Research And Development Co. Ltd. |
Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
|
ATE164853T1
(de)
|
1990-01-16 |
1998-04-15 |
Orgenics Ltd |
Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
|
US5108904A
(en)
|
1990-03-26 |
1992-04-28 |
Alan Landay |
CD44 as a marker for HIV infection
|
US5252556A
(en)
|
1990-03-30 |
1993-10-12 |
New England Medical Center Hospitals, Inc. |
Fragment capable of binding anti-CD43 autoantibodies
|
WO1991015238A1
(en)
|
1990-04-03 |
1991-10-17 |
Genentech, Inc. |
Methods and compositions for vaccination against hiv
|
FR2660757B1
(fr)
|
1990-04-06 |
1994-05-27 |
Immunotech Sa |
Procede d'identification ou de dosage de proteines et applications.
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5344755A
(en)
|
1990-04-21 |
1994-09-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for detecting immune system dysfunction in asymptomatic, HIV-scropositive individuals
|
US6034233A
(en)
|
1990-05-04 |
2000-03-07 |
Isis Pharmaceuticals Inc. |
2'-O-alkylated oligoribonucleotides and phosphorothioate analogs complementary to portions of the HIV genome
|
JPH05507491A
(ja)
|
1990-05-16 |
1993-10-28 |
デイナ・フアーバー・キヤンサー・インステイテユート |
免疫原性ペプチド、抗体、及び、cd4レセプター結合に関するそれらの用途
|
AP237A
(en)
|
1990-05-29 |
1993-04-29 |
Cedars Sinai Medical Center |
Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
|
US5527894A
(en)
|
1990-06-11 |
1996-06-18 |
Nexstar Pharmacueticals, Inc. |
Ligands of HIV-1 tat protein
|
US5914109A
(en)
|
1990-06-15 |
1999-06-22 |
New York University |
Heterohybridomas producing human monoclonal antibodies to HIV-1
|
US5178865A
(en)
|
1990-06-19 |
1993-01-12 |
Cedars-Sinai Medical Center |
Chinese herbal extracts in the treatment of hiv related disease in vitro
|
US5709879A
(en)
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
US5230887A
(en)
|
1990-07-11 |
1993-07-27 |
Immune Network Research Ltd. |
Immune system stabilizers for prevention and therapy of disorders associated with immune system disfunction
|
GB9016973D0
(en)
|
1990-08-02 |
1990-09-19 |
Medical Res Council |
Viral growth inhibition
|
EP0564460B1
(en)
|
1990-08-16 |
1998-10-21 |
Diagnostic Biotechnology, Inc. |
An augmented western blot format and immunoassay for detection of viral antibodies
|
US5541100A
(en)
|
1990-09-12 |
1996-07-30 |
Rutgers University |
Chimeric rhinoviruses
|
US5714374A
(en)
|
1990-09-12 |
1998-02-03 |
Rutgers University |
Chimeric rhinoviruses
|
WO1992005192A1
(en)
|
1990-09-18 |
1992-04-02 |
Biotech Australia Pty. Limited |
T-cell epitopes
|
US5786145A
(en)
|
1990-09-20 |
1998-07-28 |
Medical Research Council |
Oligonucleotide competitors for binding of HIV RRE to REV protein and assays for screening inhibitors of this binding
|
JP3895366B2
(ja)
|
1990-09-25 |
2007-03-22 |
キャンタブ ファーマシューティカルズ リサーチ リミティド |
ウィルス ワクチン
|
ATE153138T1
(de)
|
1990-09-26 |
1997-05-15 |
Akers Lab Inc |
Verbessertes bestimmungsverfahren für liganden
|
US6248332B1
(en)
|
1990-10-05 |
2001-06-19 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
WO1992007269A1
(en)
|
1990-10-11 |
1992-04-30 |
Pro-Soma S.A.R.L. |
Diagnostic method
|
JP3011987B2
(ja)
|
1990-10-11 |
2000-02-21 |
旭化成工業株式会社 |
固相化プライマーを用いる逆転写酵素の測定法
|
US5866137A
(en)
|
1990-10-12 |
1999-02-02 |
Benjamin Rovinski |
Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins
|
US5753258A
(en)
|
1990-10-19 |
1998-05-19 |
University Of Florida |
Artificial viral envelopes
|
EP0554401A4
(en)
|
1990-10-26 |
1996-10-30 |
New York Health Res Inst |
Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
|
DE69126301T2
(de)
|
1990-11-27 |
1998-01-02 |
Biogen, Inc., Cambridge, Mass. |
Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
|
US5780279A
(en)
|
1990-12-03 |
1998-07-14 |
Genentech, Inc. |
Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
|
ES2113940T3
(es)
|
1990-12-03 |
1998-05-16 |
Genentech Inc |
Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
US6407221B1
(en)
|
1990-12-14 |
2002-06-18 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
EP0517895B1
(en)
|
1990-12-14 |
1996-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
US6319494B1
(en)
|
1990-12-14 |
2001-11-20 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
US5087631A
(en)
|
1990-12-18 |
1992-02-11 |
Glaxo Inc. |
Oxathi(SIV)azol-5-one compounds
|
US5876716A
(en)
|
1991-01-24 |
1999-03-02 |
Bay Development Corporation Sa |
Method of using an antibody to the TN antigen for the inhibition of HIV infection
|
US5296347A
(en)
|
1991-02-08 |
1994-03-22 |
Ciba Corning Diagnostics Corp. |
Bridge immunoassay
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
DE4112440C1
(lt)
|
1991-04-16 |
1992-10-22 |
Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De |
|
GB9108386D0
(en)
|
1991-04-19 |
1991-06-05 |
Agricultural Genetics Co |
Modified plant viruses as vectors
|
CA2109093A1
(en)
|
1991-04-30 |
1992-10-31 |
Bernard Malfroy-Camine |
Cationized antibodies against intracellular proteins
|
US5879685A
(en)
|
1991-05-08 |
1999-03-09 |
Schweiz, Serum- & Impfinstitut Bern |
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
|
WO1992020813A1
(en)
|
1991-05-17 |
1992-11-26 |
Dana Farber Cancer Institute |
Assays for factors affecting circularization of dna, assays for factors affecting dna integration, factors, and uses thereof
|
JP3220180B2
(ja)
|
1991-05-23 |
2001-10-22 |
三菱化学株式会社 |
薬剤含有タンパク質結合リポソーム
|
FR2677654B1
(fr)
|
1991-06-17 |
1995-11-17 |
Pasteur Merieux Serums Vacc |
Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
|
US5637481A
(en)
|
1993-02-01 |
1997-06-10 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
EP1092775A1
(en)
*
|
1991-07-05 |
2001-04-18 |
American Cyanamid Company |
Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus
|
US5223408A
(en)
|
1991-07-11 |
1993-06-29 |
Genentech, Inc. |
Method for making variant secreted proteins with altered properties
|
US5709860A
(en)
|
1991-07-25 |
1998-01-20 |
Idec Pharmaceuticals Corporation |
Induction of cytotoxic T-lymphocyte responses
|
US5585103A
(en)
|
1991-07-25 |
1996-12-17 |
Idec Pharmaceutical Corporation |
Induction of cytotoxic T-lymphocyte responses
|
US5230998A
(en)
|
1991-07-25 |
1993-07-27 |
Neurath Alexander R |
Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120
|
US5558865A
(en)
|
1991-08-22 |
1996-09-24 |
Nissin Shokuhin Kabushiki Kaisha |
HIV immunotherapeutics
|
AU2547592A
(en)
|
1991-08-23 |
1993-03-16 |
Isis Pharmaceuticals, Inc. |
Synthetic unrandomization of oligomer fragments
|
US5317009A
(en)
|
1991-08-26 |
1994-05-31 |
New York University |
Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
|
US5418136A
(en)
|
1991-10-01 |
1995-05-23 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
WO1993008216A1
(en)
|
1991-10-15 |
1993-04-29 |
New York University |
Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv
|
US5707814A
(en)
|
1991-11-01 |
1998-01-13 |
The Regents Of The University Of California |
CD8+ cell antiviral factor
|
US5512281A
(en)
|
1991-11-05 |
1996-04-30 |
Dana-Farber Cancer Institute, Inc. |
Mammalian model system and methods of testing immuno-or drug prophylaxis of fetal infection by HIV-1 or other lentiviruses
|
US5688511A
(en)
|
1991-11-05 |
1997-11-18 |
Board Of Regents, The University Of Texas System |
Cellular protein TDP-43 and regulation of HIV-1 gene expression
|
US5260308A
(en)
|
1991-11-06 |
1993-11-09 |
Mayo Foundation For Medical Education And Research |
Method to increase permeability of the blood-nerve/brain barriers to proteins
|
US5976551A
(en)
|
1991-11-15 |
1999-11-02 |
Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and method of using the determinant
|
US6153408A
(en)
|
1991-11-15 |
2000-11-28 |
Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
JPH08503121A
(ja)
|
1991-12-10 |
1996-04-09 |
デイナ・フアーバー・キヤンサー・インステイテユート |
中和反応性ヒト抗−gp120組換え抗体、それをコードするdnaおよびその使用
|
CA2084180A1
(en)
|
1991-12-11 |
1993-06-12 |
Paul P. Hung |
Expression of specific immunogens using viral antigens
|
US5256561A
(en)
|
1991-12-20 |
1993-10-26 |
Abbott Laboratories |
Monoclonal antibody to HIV-2 and uses thereof
|
ATE329054T1
(de)
|
1991-12-23 |
2006-06-15 |
Chiron Corp |
Sätze von hiv sonden für solution sandwich hybridationsverfahren
|
US5587285A
(en)
|
1992-01-31 |
1996-12-24 |
University Of Texas System |
Generation serological assay for monitoring HIV exposure
|
IL100841A
(en)
|
1992-01-31 |
1999-08-17 |
Bystryak Seymon |
Immunoassay involving photoirradiation and detection of optical density or fluorescence
|
FR2687410A1
(fr)
|
1992-02-14 |
1993-08-20 |
Pasteur Institut |
Beta-lactamase recombinante, utilisable en tant que molecule porteuse pour la preparation de compositions immunogenes.
|
EP0671920B1
(en)
|
1992-03-09 |
2003-12-10 |
San Diego Regional Cancer Center |
An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
|
US5643578A
(en)
|
1992-03-23 |
1997-07-01 |
University Of Massachusetts Medical Center |
Immunization by inoculation of DNA transcription unit
|
US6103238A
(en)
|
1992-03-13 |
2000-08-15 |
President And Fellows Of Harvard College |
Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
|
US5422277A
(en)
|
1992-03-27 |
1995-06-06 |
Ortho Diagnostic Systems Inc. |
Cell fixative composition and method of staining cells without destroying the cell surface
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US6004807A
(en)
|
1992-03-30 |
1999-12-21 |
Schering Corporation |
In vitro generation of human dendritic cells
|
WO1993020207A1
(en)
|
1992-04-02 |
1993-10-14 |
The United States Of America, As Represented By The Secretary Of Health And Human Services |
Use of restriction endonucleases against viruses, including hiv
|
ES2290950T3
(es)
|
1992-04-21 |
2008-02-16 |
Institut Pasteur |
Mutantes recombinantes para inducir respuestas inmunitarias especificas.
|
US5935580A
(en)
|
1992-04-21 |
1999-08-10 |
Institut Pasteur |
Recombinant mutants for inducing specific immune responses
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
US5580563A
(en)
|
1992-05-01 |
1996-12-03 |
Tam; James P. |
Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
|
IT1254360B
(it)
|
1992-05-11 |
1995-09-14 |
San Romanello Centro Fond |
Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
|
FR2691162B1
(fr)
|
1992-05-12 |
1994-07-08 |
Aremas |
Moyen pour le dosage quantitatif de retrovirus, procede pour sa preparation et kit de diagnostic comportant ledit moyen.
|
EP0570357B1
(en)
|
1992-05-14 |
1997-06-25 |
Polymun Scientific Immunbiologische Forschung GmbH |
Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
|
WO1993024632A1
(en)
|
1992-05-22 |
1993-12-09 |
Dana Farber Cancer Institute |
Hybrid siv/hiv-1 viral vectors and monkey model for aids
|
US5580773A
(en)
|
1992-06-17 |
1996-12-03 |
Korea Green Cross Corporation |
Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
|
US5843640A
(en)
|
1992-06-19 |
1998-12-01 |
Northwestern University |
Method of simultaneously detecting amplified nucleic acid sequences and cellular antigens in cells
|
ES2108278T3
(es)
|
1992-06-25 |
1997-12-16 |
Smithkline Beecham Biolog |
Composicion de vacuna con coadyuvantes.
|
US5650398A
(en)
|
1992-07-02 |
1997-07-22 |
Cambridge Biotech Corporation |
Drug delivery enhancement via modified saponins
|
EP0651805B1
(en)
|
1992-07-17 |
2006-12-13 |
Dana Farber Cancer Institute |
Method of intracellular binding of target molecules
|
US5736146A
(en)
|
1992-07-30 |
1998-04-07 |
Yeda Research And Development Co. Ltd. |
Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
|
US5447838A
(en)
|
1992-08-05 |
1995-09-05 |
Hybritech Incorporated |
Protein-dye conjugate for confirmation of correct dilution of calibrators
|
US6511845B1
(en)
|
1992-08-07 |
2003-01-28 |
Alan R. Davis |
Methods for producing an immune response against HIV-1
|
HUT71860A
(en)
|
1992-08-27 |
1996-02-28 |
Deakin Res Ltd |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
US5643756A
(en)
|
1992-08-28 |
1997-07-01 |
The Public Health Research Institute Of The City Of New York, Inc. |
Fusion glycoproteins
|
US6004763A
(en)
|
1992-09-11 |
1999-12-21 |
Institut Pasteur |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
CA2105629A1
(en)
|
1992-09-14 |
1994-03-15 |
Robert S. Becker |
Potentiation of immunogenic response
|
US5686078A
(en)
|
1992-09-14 |
1997-11-11 |
Connaught Laboratories, Inc. |
Primary and secondary immunization with different physio-chemical forms of antigen
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
AU678415B2
(en)
|
1992-10-05 |
1997-05-29 |
Hybridon, Inc. |
Therapeutic anti-HIV oligonucleotide and pharmaceutical
|
ATE174382T1
(de)
|
1992-10-06 |
1998-12-15 |
Dade Behring Marburg Gmbh |
Retrovirus aus der hiv-gruppe und dessen verwendung
|
US6153378A
(en)
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
US5462852A
(en)
|
1992-10-28 |
1995-10-31 |
The Government Of The United States Of America, As Represented By The Secretary, Dhhs |
HIV Nucleocapsid protein capture assay and method of use
|
US5391479A
(en)
|
1992-10-29 |
1995-02-21 |
E. I. Du Pont De Nemours And Company |
Method for determining total analyte concentration in a sample having both free and bound analyte
|
US5891623A
(en)
|
1992-11-09 |
1999-04-06 |
Consorzio Per Le Biotecnologie |
Diagnosis and treatment of AIDS onset
|
WO1994011027A1
(en)
|
1992-11-13 |
1994-05-26 |
Board Of Regents Of University Of Washington |
Peripheralization of hematopoietic stem cells
|
US5384240A
(en)
|
1992-11-25 |
1995-01-24 |
Akzo Nobel, N.V. |
Base dissociation assay
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
GB9227068D0
(en)
|
1992-12-29 |
1993-02-24 |
British Bio Technology |
Novel proteinaceous particles
|
JPH08506012A
(ja)
|
1992-12-31 |
1996-07-02 |
ラモツト・ユニバーシテイ・オーソリテイ・フオー・アプライド・リサーチ・アンド・インダストリアル・デベロツプメント・リミテツド |
結合・連動性エピトープに対する抗体
|
DK0678523T3
(da)
|
1993-01-14 |
2005-01-10 |
Chemo Sero Therapeut Res Inst |
Rekombinant anti-HIV antistof og fremstilling deraf
|
WO1994016081A1
(de)
|
1993-01-16 |
1994-07-21 |
Manfred Schawaller |
Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
US7001759B1
(en)
|
1993-01-26 |
2006-02-21 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
FR2701319B1
(fr)
|
1993-02-09 |
1995-04-21 |
Elie Stefas |
Procédé de détection et/ou de dosage de composés viraux et support portant une glycoprotéine.
|
DK17093D0
(da)
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
WO1994019482A1
(en)
|
1993-02-22 |
1994-09-01 |
The General Hospital Corporation |
Heterologous antigens in live cell vaccine strains
|
US5470701A
(en)
|
1993-02-24 |
1995-11-28 |
The Regents Of The University Of California |
Method for determining favorable prognosis in an HIV positive subject using HLA-DR+ /CD38- CD8bright cells
|
US5817767A
(en)
|
1993-02-24 |
1998-10-06 |
Progenics Pharmaceuticals, Inc. |
Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
|
EP0690132B1
(en)
|
1993-03-11 |
2003-12-17 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Anti-hiv monoclonal antibody
|
US5607831A
(en)
|
1993-03-25 |
1997-03-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death
|
US6495676B1
(en)
|
1993-04-13 |
2002-12-17 |
Naxcor |
Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
|
US6323185B1
(en)
|
1993-04-23 |
2001-11-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-viral guanosine-rich oligonucleotides and method of treating HIV
|
ES2166779T3
(es)
|
1993-05-07 |
2002-05-01 |
Bio Merieux Inc |
Complejos inmunogenicos del hiv.
|
AT399054B
(de)
|
1993-05-12 |
1995-03-27 |
Thomas Dr Schlederer |
Verfahren zum nachweis von substanzen
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US5795572A
(en)
|
1993-05-25 |
1998-08-18 |
Bristol-Myers Squibb Company |
Monoclonal antibodies and FV specific for CD2 antigen
|
DK0700445T3
(da)
|
1993-06-04 |
2002-05-13 |
Whitehead Biomedical Inst |
Stressproteiner og anvendelser deraf
|
CA2164505A1
(en)
|
1993-06-07 |
1994-12-22 |
Phillip W. Berman |
Hiv envelope polypeptides
|
US6017536A
(en)
|
1993-06-07 |
2000-01-25 |
Trimeris, Inc. |
Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
|
CN1111540C
(zh)
|
1993-06-09 |
2003-06-18 |
康诺特实验室有限公司 |
串联的合成hiv-1肽类
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
US5861242A
(en)
|
1993-06-25 |
1999-01-19 |
Affymetrix, Inc. |
Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same
|
US5478753A
(en)
|
1993-06-29 |
1995-12-26 |
Pb Diagnostic Systems, Inc. |
Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
|
US5614413A
(en)
|
1993-07-01 |
1997-03-25 |
The Uab Research Foundation |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
CA2125344A1
(en)
|
1993-07-01 |
1995-01-02 |
Casey D. Morrow |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
US5981259A
(en)
|
1993-07-07 |
1999-11-09 |
University Technology Corporation |
CD4+ T-lymphocyte protease genes and inhibitors thereof
|
US5470572A
(en)
|
1993-07-16 |
1995-11-28 |
University Of Puerto Rico |
Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
|
US5354654A
(en)
|
1993-07-16 |
1994-10-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Lyophilized ligand-receptor complexes for assays and sensors
|
US5851829A
(en)
|
1993-07-16 |
1998-12-22 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
US5728385A
(en)
|
1993-08-12 |
1998-03-17 |
Classen Immunotherapies, Inc. |
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
|
US5543328A
(en)
|
1993-08-13 |
1996-08-06 |
Genetic Therapy, Inc. |
Adenoviruses having modified fiber proteins
|
US5585250A
(en)
|
1993-08-20 |
1996-12-17 |
The United States Of America As Represented By The Department Of Health & Human Services |
Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
|
CA2170034C
(en)
|
1993-08-24 |
2005-03-15 |
Joseph William Harris |
Recombinant humanized anti-human immunodeficiency virus antibody
|
FR2709309B1
(fr)
|
1993-08-25 |
1995-11-10 |
Centre Nat Rech Scient |
Compositions cellulaires, préparation et utilisations thérapeutiques.
|
US5762939A
(en)
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
US5510264A
(en)
|
1993-09-28 |
1996-04-23 |
Insight Biotech Inc. |
Antibodies which bind meningitis related homologous antigenic sequences
|
WO1995010777A1
(en)
|
1993-10-15 |
1995-04-20 |
Rakowicz Szulczynska Ewa M |
Detection and treatment of breast and gynecological cancer
|
KR100235849B1
(ko)
|
1993-10-19 |
1999-12-15 |
에가시라 구니오 |
HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS)
|
CA2174532A1
(en)
|
1993-10-19 |
1995-04-27 |
Carlos F. Barbas |
Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
|
US6074646A
(en)
|
1993-10-26 |
2000-06-13 |
Board Of Regents, The University Of Texas System |
Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
|
US5961970A
(en)
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5985926A
(en)
|
1993-11-01 |
1999-11-16 |
Cell Therapeutics, Inc. |
Method for inhibiting intracellular viral replication
|
KR100354309B1
(ko)
|
1993-11-12 |
2003-01-06 |
파마시아 앤드 업존 캄파니 |
피리미딘-티오알킬및알킬에테르화합물
|
US6025141A
(en)
|
1993-12-10 |
2000-02-15 |
The Canadian Red Cross Society |
Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
|
US5667783A
(en)
|
1993-12-13 |
1997-09-16 |
Constantine Alen |
Method of treating HIV positive subjects
|
EP0659885A1
(en)
|
1993-12-21 |
1995-06-28 |
Akzo Nobel N.V. |
Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
US5712384A
(en)
|
1994-01-05 |
1998-01-27 |
Gene Shears Pty Ltd. |
Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
|
US5955647A
(en)
|
1994-02-03 |
1999-09-21 |
The Scripps Research Institute |
Method for using tobacco mosaic virus to overproduce peptides and proteins
|
US6015661A
(en)
|
1994-02-14 |
2000-01-18 |
The Macfarlane Burnet Centre For Medical Research Limited |
Methods for the detection of non-pathogenic HIV-1 strains containing deletions in the Nef coding region and U3 region of the LTR
|
ATE362977T1
(de)
|
1994-02-14 |
2007-06-15 |
Macfarlane Burnet Ct For Medic |
Nicht pathogene stämme des hiv-1
|
US5569468A
(en)
|
1994-02-17 |
1996-10-29 |
Modi; Pankaj |
Vaccine delivery system for immunization, using biodegradable polymer microspheres
|
DE4405810A1
(de)
|
1994-02-23 |
1995-08-24 |
Behringwerke Ag |
Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
|
US6995008B1
(en)
|
1994-03-07 |
2006-02-07 |
Merck & Co., Inc. |
Coordinate in vivo gene expression
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
JPH09512177A
(ja)
|
1994-04-29 |
1997-12-09 |
ファルマシア・アンド・アップジョン・カンパニー |
ネコ免疫不全ウイルスワクチン
|
US6511812B1
(en)
|
1994-05-09 |
2003-01-28 |
Abbott Laboratories |
Method and test kit for use in improving immunoassay specificity
|
US5639598A
(en)
|
1994-05-19 |
1997-06-17 |
The Trustees Of The University Of Pennsylvania |
Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
|
US5573916A
(en)
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
US5585263A
(en)
|
1994-05-20 |
1996-12-17 |
University Of Alabama At Birmingham Research Foundation |
Purified retroviral constitutive transport enhancer and its use to facilitate mRNA transport, and to produce recombinant, attenuated HIV
|
US6222024B1
(en)
|
1994-05-24 |
2001-04-24 |
The Trustees Of Columbia University In The City Of New York |
Nucleic acids encoding a human immunodeficiency virus type 1 (HIV-1) integrase interactor protein (INI-1)
|
US5773225A
(en)
|
1994-05-24 |
1998-06-30 |
The Trustees Of Columbia University In The City Of New York |
Screening method for the identification of compounds capable of abrogation HIV-1 gag-cyclophilin complex formation
|
US5869058A
(en)
|
1994-05-25 |
1999-02-09 |
Yeda Research And Development Co. Ltd. |
Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
|
US6355247B1
(en)
|
1994-06-02 |
2002-03-12 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
US5641624A
(en)
|
1994-06-02 |
1997-06-24 |
Sloan-Kettering Institute For Cancer Research |
Method for measuring anti-HIV-1 p24 antibody and use thereof
|
US5556745A
(en)
|
1994-06-03 |
1996-09-17 |
Sch+E,Uml U+Ee Pbach; J+E,Uml O+Ee Rg |
Method for the detection and quantitative determination of antigen in a test sample containing immune complexes of antigen bound to antibodies and to rheumatoid factors
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
US6319665B1
(en)
|
1994-06-07 |
2001-11-20 |
Inverness Medical Technology, Inc. |
Home test kit and method with telephone verification of results
|
US6764682B1
(en)
|
1994-06-16 |
2004-07-20 |
Aventis Pasteur Limited |
Adjuvant compositions containing more than one adjuvant
|
US6653066B1
(en)
|
1994-06-17 |
2003-11-25 |
Trinity Biotech |
Device and method for detecting polyvalent substances
|
GB9414118D0
(en)
|
1994-07-13 |
1994-08-31 |
Axis Genetics Ltd |
Modified plant viruses as vectors of heterologous peptides
|
US5618922A
(en)
|
1994-07-25 |
1997-04-08 |
Nissin Shokuhin Kabushiki Kaisha |
NM03 antibody materials and methods
|
EP0774120B1
(de)
|
1994-07-25 |
2009-08-26 |
Roche Diagnostics GmbH |
Metallchelat-markierte peptide
|
NZ291153A
(en)
|
1994-07-25 |
1999-01-28 |
Boehringer Mannheim Gmbh |
Determination of a specific antibody using multiple antigens containing several epitope regions which react with the antibody
|
NZ291155A
(en)
|
1994-07-25 |
1997-09-22 |
Boehringer Mannheim Gmbh |
Production of hapten labelled peptides and their use
|
US5846806A
(en)
*
|
1994-07-29 |
1998-12-08 |
American Cyanamid Company |
Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
|
US5885580A
(en)
|
1994-07-29 |
1999-03-23 |
Ajinomoto Co., Inc. |
Anti-AIDS secretory recombinant BCG vaccine
|
US5686578A
(en)
|
1994-08-05 |
1997-11-11 |
Immunomedics, Inc. |
Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
|
US5733760A
(en)
|
1994-08-05 |
1998-03-31 |
Virus Research Institute |
Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof
|
US5627025A
(en)
|
1994-08-12 |
1997-05-06 |
The Rockefeller University |
Method for the identification of compounds capable of abrogating human immunodeficiency virus (HIV) infection of dendritic cells and T-lymphocytes
|
US5955342A
(en)
|
1994-08-15 |
1999-09-21 |
Connaught Laboratories Limited |
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
|
US6291157B1
(en)
|
1998-02-23 |
2001-09-18 |
Connaught Laboratories Limited |
Antigenically-marked non-infectious retrovirus-like particles
|
US5858838A
(en)
|
1998-02-23 |
1999-01-12 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
|
FI98961C
(fi)
|
1994-08-26 |
1997-09-10 |
Medix Biochemica Ab Oy |
Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
|
US6436407B1
(en)
|
1994-08-26 |
2002-08-20 |
The Administrators Of The Tulane Educational Fund |
Mutant enterotoxin effective as a non-toxic adjuvant
|
AU3541495A
(en)
|
1994-09-01 |
1996-03-22 |
Wisconsin Alumni Research Foundation |
Therapeutic remodeling in aids
|
US5861161A
(en)
|
1994-09-07 |
1999-01-19 |
Universite De Montreal |
Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions
|
US5698446A
(en)
|
1994-09-07 |
1997-12-16 |
Chiron Corporation |
Methods and compositions for inhibiting production of replication competent virus
|
US5766842A
(en)
|
1994-09-16 |
1998-06-16 |
Sepracor, Inc. |
In vitro method for predicting the evolutionary response of a protein to a drug targeted thereagainst
|
US5763190A
(en)
|
1994-09-21 |
1998-06-09 |
The Trustees Of The University Of Pennsylvania |
Methods for the identification of compounds capable of inducing the nuclear translocation of a receptor complex comprising the glucocoticoid receptor type II and viral protein R interacting protein
|
US6001555A
(en)
|
1994-09-23 |
1999-12-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
|
AU688606B2
(en)
|
1994-10-03 |
1998-03-12 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
|
US6376170B1
(en)
|
1994-10-03 |
2002-04-23 |
The Scripps Research Institute |
Ligand capture-directed selection of antibody
|
GB2294047A
(en)
|
1994-10-14 |
1996-04-17 |
Merck & Co Inc |
Synthetic peptides for use as epitopes specific for HIV
|
US5667964A
(en)
|
1994-10-28 |
1997-09-16 |
Cornell Research Foundation, Inc. |
Rapid, direct, and qualitative method for the determination of the number of HIV-1-infected patient cells employing reactive oxygen intermediate generators
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
US6124132A
(en)
|
1994-11-07 |
2000-09-26 |
Blake Laboratories, Inc. |
Use of anti-HIV IGA antibodies for producing immunological protection against the human immunodeficiency virus
|
US5695938A
(en)
|
1994-12-09 |
1997-12-09 |
City Of Hope |
Anti-HIV ribozymes
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
DE19504211A1
(de)
|
1995-02-09 |
1996-08-14 |
Behringwerke Ag |
Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
|
US5824497A
(en)
|
1995-02-10 |
1998-10-20 |
Mcmaster University |
High efficiency translation of mRNA molecules
|
US6548635B1
(en)
|
1995-02-16 |
2003-04-15 |
Dade Behring Marburg Gmbh |
Retrovirus from the HIV type O and its use (MVP-2901/94)
|
DE19505262C2
(de)
|
1995-02-16 |
1998-06-18 |
Behring Diagnostics Gmbh |
Retrovirus aus der HIV-Gruppe und dessen Verwendung
|
US5658745A
(en)
|
1995-02-17 |
1997-08-19 |
E. I. Du Pont De Nemours And Company |
Cell enumeration immunoassay
|
FR2730735B1
(fr)
|
1995-02-20 |
1997-05-09 |
Pasteur Institut |
Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales
|
AU711121B2
(en)
|
1995-02-21 |
1999-10-07 |
Cantab Pharmaceuticals Research Limited |
Viral preparations, vectors, immunogens, and vaccines
|
US5843635A
(en)
|
1995-02-27 |
1998-12-01 |
Dana-Farber Cancer Institute, Inc. |
Inhibition of APC-mediated apoptosis of activated T lymphocytes
|
FR2731013B1
(fr)
|
1995-02-27 |
1997-05-16 |
Inst Nat Sante Rech Med |
Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
|
US5736317A
(en)
|
1995-03-07 |
1998-04-07 |
Akzo Nobel N.V. |
Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium
|
US5817470A
(en)
|
1995-03-10 |
1998-10-06 |
Sociedad Biotecnologica Collico Limitada |
Immobilization of antigens to solid support by the mussel adhesive polyphenolic protein and the method for use therein
|
WO1996029421A1
(en)
|
1995-03-23 |
1996-09-26 |
Cantab Pharmaceuticals Research Limited |
Vectors for gene delivery
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
JPH11503024A
(ja)
|
1995-04-04 |
1999-03-23 |
セル・ジェネシス・インコーポレイテッド |
細胞表面のクラスi mhcタンパク質の低レベルを有する遺伝子学的に修飾された細胞の移植
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
US6838477B2
(en)
|
1995-04-12 |
2005-01-04 |
President And Fellows Of Harvard College |
Lactacystin analogs
|
US6335358B1
(en)
|
1995-04-12 |
2002-01-01 |
President And Fellows Of Harvard College |
Lactacystin analogs
|
US5645836A
(en)
|
1995-04-14 |
1997-07-08 |
Research Development Foundation |
Anti-AIDS immunotoxins
|
WO1996032494A1
(en)
|
1995-04-14 |
1996-10-17 |
University Of Alabama Research Foundation |
Fusion protein delivery system and uses thereof
|
AR003941A1
(es)
|
1995-04-19 |
1998-09-30 |
Polymun Scient Immunbilogische Forschung Gmbh |
Anticuerpos monoclonales humanos neutralizadores de hiv-1
|
MX9708008A
(es)
|
1995-04-19 |
1998-03-31 |
Polymun Scient Immunbio Forsch |
Anticuerpos monoclonales contra vih-1 y vacunas hechas de los mismos.
|
US6428790B1
(en)
|
1995-04-27 |
2002-08-06 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services |
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
|
US6987096B1
(en)
|
1995-04-27 |
2006-01-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
|
UA56992C2
(uk)
|
1995-05-08 |
2003-06-16 |
Фармація Енд Апджон Компані |
<font face="Symbol">a</font>-ПІРИМІДИНТІОАЛКІЛЗАМІЩЕНІ ТА <font face="Symbol">a</font>-ПІРИМІДИНОКСОАЛКІЛЗАМІЩЕНІ СПОЛУКИ
|
US5874226A
(en)
|
1995-05-22 |
1999-02-23 |
H. Lee Browne |
In situ immunodetection of antigens
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US6007838A
(en)
|
1995-06-07 |
1999-12-28 |
The United States Of America As Represented By The Secretary Of The Army |
Process for making liposome preparation
|
US7223739B1
(en)
|
1995-06-07 |
2007-05-29 |
Powderject Vaccines, Inc. |
Adjuvanted genetic vaccines
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
AU723158B2
(en)
|
1995-06-07 |
2000-08-17 |
Progenics Pharmaceuticals, Inc. |
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
|
US6114507A
(en)
|
1995-06-30 |
2000-09-05 |
Mochida Pharmaceutical Co., Ltd. |
Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
|
UA68327C2
(en)
|
1995-07-04 |
2004-08-16 |
Gsf Forschungszentrum Fur Unwe |
A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
|
US6326007B1
(en)
|
1995-07-20 |
2001-12-04 |
The Regents Of The University Of California |
Attenuated lentivirus vectors expressing interferon
|
JPH11514341A
(ja)
|
1995-08-18 |
1999-12-07 |
ドクトル・レンチュラー・ビオテヒノロギー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
Ifn−受容体にレトロウイルスが結合するのを競合的に抑制する医薬組成物およびhiv感染の診断方法
|
US5660990A
(en)
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
JP3840521B2
(ja)
|
1995-08-21 |
2006-11-01 |
Aspion株式会社 |
ウイルス検出方法およびウイルス検査用キット
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
US5993812A
(en)
|
1995-09-14 |
1999-11-30 |
Cangene Corporation |
Method of delaying the progression of an infection with the human immunodeficiency virus
|
US5705522A
(en)
|
1995-09-15 |
1998-01-06 |
Compagnie De Developpement Aguettant S.A. |
Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
|
AU6996396A
(en)
|
1995-09-22 |
1997-04-09 |
Medical Research Council |
Improvements in or relating to mutagenesis of nucleic acids
|
DE19541450C2
(de)
|
1995-11-07 |
1997-10-02 |
Gsf Forschungszentrum Umwelt |
Genkonstrukt und dessen Verwendung
|
US5888767A
(en)
|
1996-11-27 |
1999-03-30 |
The Johns Hopkins University School Of Medicine |
Method of using a conditionally replicating viral vector to express a gene
|
EP0877940A1
(en)
|
1995-12-05 |
1998-11-18 |
Donald R. Branch |
Methods for the early detection of hiv infection
|
US6265184B1
(en)
|
1995-12-20 |
2001-07-24 |
Icos Corporation |
Polynucleotides encoding chemokine receptor 88C
|
US5919457A
(en)
|
1996-01-11 |
1999-07-06 |
Regents Of The University Of Minnesota |
TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment of AIDS
|
US6406710B1
(en)
|
1996-01-16 |
2002-06-18 |
Nikos Panayotatos |
Protein occlusion for delivery of small molecules
|
US7118859B2
(en)
|
1996-01-17 |
2006-10-10 |
Progenics Pharmaceuticals, Inc. |
Methods for inhibiting HIV-1 infection
|
CU22559A1
(es)
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
US6495526B2
(en)
|
1996-01-23 |
2002-12-17 |
Gpc Biotech, Inc. |
Inhibitors of cell-cycle progression and uses related thereto
|
US5747526A
(en)
|
1996-01-25 |
1998-05-05 |
Hollinshead; Ariel C. |
Anti-HIV /Aids Chemo(C)-, immuno(I)-, or ci-therapy using tur (or related compounds) and/or NVA (or EPV)
|
US6060587A
(en)
|
1996-01-29 |
2000-05-09 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
|
US6703394B2
(en)
|
1996-02-16 |
2004-03-09 |
Medivir Ab |
Acyclic nucleoside derivatives
|
US5869493A
(en)
|
1996-02-16 |
1999-02-09 |
Medivir Ab |
Acyclic nucleoside derivatives
|
US6534312B1
(en)
|
1996-02-22 |
2003-03-18 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
US6509313B1
(en)
|
1996-02-28 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Stimulation of immune response with low doses of cytokines
|
US6045788A
(en)
|
1996-02-28 |
2000-04-04 |
Cornell Research Foundation, Inc. |
Method of stimulation of immune response with low doses of IL-2
|
US5840305A
(en)
|
1996-03-14 |
1998-11-24 |
The Picower Institute For Medical Research |
Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity
|
US6033672A
(en)
|
1996-03-15 |
2000-03-07 |
University Of Southern California |
Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens
|
US5985545A
(en)
|
1996-03-19 |
1999-11-16 |
Yamamoto; Nobuto |
Diagnostic and prognostic ELISA assays of serum α-N-acetylgalactosaminidase for AIDS
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
US5950176A
(en)
|
1996-03-25 |
1999-09-07 |
Hsx, Inc. |
Computer-implemented securities trading system with a virtual specialist function
|
US6344545B1
(en)
|
1996-06-14 |
2002-02-05 |
Progenics Pharmaceuticals, Inc. |
Method for preventing HIV-1 infection of CD4+ cells
|
US5866341A
(en)
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
US6458560B1
(en)
|
1996-04-05 |
2002-10-01 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
US6225045B1
(en)
|
1996-05-13 |
2001-05-01 |
Ribotargets, Ltd. |
Assays for screening for inhibitors of HIV
|
DE19617851A1
(de)
|
1996-05-03 |
1997-11-13 |
Hoechst Ag |
Nukleinsäurekonstrukte mit Genen kodierend für Transportsignale
|
US5961976A
(en)
|
1996-06-03 |
1999-10-05 |
United Biomedical, Inc. |
Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV
|
US5741706A
(en)
|
1996-06-13 |
1998-04-21 |
Immusol, Incorporated |
Anti-HIV ribozymes
|
US6319504B1
(en)
|
1996-06-24 |
2001-11-20 |
University Of Maryland Biotechnology Institute |
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
|
US5994515A
(en)
|
1996-06-25 |
1999-11-30 |
Trustees Of The University Of Pennsylvania |
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
|
NZ333346A
(en)
|
1996-06-28 |
2000-03-27 |
Caliper Techn Corp |
High-throughput screening assay systems in microscale fluidic devices
|
US5951975A
(en)
|
1996-06-28 |
1999-09-14 |
University Of Pittsburgh |
Induction of CTLs specific for natural antigens by cross priming immunization
|
WO1998000560A2
(en)
|
1996-07-02 |
1998-01-08 |
Massachusetts Institute Of Technology |
Method for determining lymphocyte distribution and trafficking in mammals using imaging
|
JP3781780B2
(ja)
|
1996-07-02 |
2006-05-31 |
ビービーアイ バイオセク,インク. |
生体分子複合体の圧力―媒介結合
|
DE69734734D1
(de)
|
1996-07-05 |
2005-12-29 |
Us Gov Health & Human Serv |
Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
|
ZA975889B
(en)
|
1996-07-08 |
1998-02-23 |
Genentech Inc |
HIV envelope polypeptides and vaccine.
|
US6248514B1
(en)
|
1996-07-09 |
2001-06-19 |
Canji, Inc. |
Methods for measuring viral infectivity
|
DE19629444A1
(de)
|
1996-07-22 |
1998-01-29 |
Behringwerke Ag |
Sensitivitätssteigerung bei der immunchemischen Bestimmung eines Analyten
|
EP0966301B1
(en)
|
1996-07-31 |
2005-02-09 |
Ortho-McNeil Pharmaceutical, Inc. |
Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression
|
US6057102A
(en)
|
1996-08-08 |
2000-05-02 |
The Aaron Diamond Aids Research Center |
HIV coreceptor mutants
|
US6107020A
(en)
|
1996-09-20 |
2000-08-22 |
Roger Williams Hospital |
Model for protective and pathogenic roles of HIV-1 env-directed antibody dependent cellular cytotoxicity interaction with viral load, and uses thereof
|
DE19639103A1
(de)
|
1996-09-24 |
1998-03-26 |
Hoechst Ag |
Nukleinsäurekonstrukte mit Hybridpromotoren für gentherapeutische Maßnahmen
|
CN1327896C
(zh)
|
1996-10-10 |
2007-07-25 |
探针国际公司 |
治疗病毒感染的组合物及方法
|
US5817458A
(en)
|
1996-10-15 |
1998-10-06 |
The Avriel Group, Amcas Division Inc. |
Reagent system for detecting HIV-infected peripheral blood lymphocytes in whole blood
|
US6024965A
(en)
|
1996-10-18 |
2000-02-15 |
Erasums University Rotterdam |
Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection
|
US5939538A
(en)
|
1996-10-25 |
1999-08-17 |
Immusol Incorporated |
Methods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNA
|
US5962318A
(en)
|
1996-11-15 |
1999-10-05 |
St. Jude Children's Research Hospital |
Cytotoxic T lymphocyte-mediated immunotherapy
|
DE19649389A1
(de)
|
1996-11-29 |
1998-06-04 |
Boehringer Mannheim Gmbh |
Antigenspezifischer IgM-Nachweis
|
DE19649390A1
(de)
|
1996-11-29 |
1998-06-04 |
Boehringer Mannheim Gmbh |
Antigenspezifischer IgG-Nachweis
|
US6231859B1
(en)
|
1996-12-02 |
2001-05-15 |
Aquila Biopharmaceuticals, Inc. |
Saponin adjuvant compositions
|
US6039684A
(en)
|
1997-12-11 |
2000-03-21 |
Allegheny University Of The Health Sciences |
Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome
|
US5922550A
(en)
|
1996-12-18 |
1999-07-13 |
Kimberly-Clark Worldwide, Inc. |
Biosensing devices which produce diffraction images
|
ATE317979T1
(de)
|
1996-12-19 |
2006-03-15 |
Dade Behring Marburg Gmbh |
Immundissoziation zur verbesserung der immunchemischen bestimmung eines analyten
|
US6096291A
(en)
|
1996-12-27 |
2000-08-01 |
Biovector Therapeutics, S.A. |
Mucosal administration of substances to mammals
|
US6245331B1
(en)
|
1997-01-02 |
2001-06-12 |
New York Univ. Medical Center |
Early detection of mycobacterial disease
|
US5766944A
(en)
|
1996-12-31 |
1998-06-16 |
Ruiz; Margaret Eileen |
T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
|
US6506384B1
(en)
|
1997-12-31 |
2003-01-14 |
New York University |
Early detection of mycobacterial disease
|
WO1998029121A1
(en)
|
1997-01-02 |
1998-07-09 |
Thomas Jefferson University |
A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
|
US6063905A
(en)
|
1997-01-07 |
2000-05-16 |
Board Of Regents, The University Of Texas System |
Recombinant human IGA-J. chain dimer
|
US6197531B1
(en)
|
1997-01-22 |
2001-03-06 |
Center For Blood Research, Inc. |
Method for determining the immunocompetence of a mammal and therapies related thereto
|
US6884435B1
(en)
|
1997-01-30 |
2005-04-26 |
Chiron Corporation |
Microparticles with adsorbent surfaces, methods of making same, and uses thereof
|
US6593103B1
(en)
|
1997-02-07 |
2003-07-15 |
The Regents Of The University Of California |
HIV capsid assembly-associated compositions and method
|
US6696291B2
(en)
|
1997-02-07 |
2004-02-24 |
Merck & Co., Inc. |
Synthetic HIV gag genes
|
EP0860445A1
(en)
|
1997-02-18 |
1998-08-26 |
Hoechst Aktiengesellschaft |
New nucleotide sequences for the cell cycle regulated expression of structural genes
|
DK0975783T3
(da)
|
1997-02-27 |
2002-01-28 |
Bundesrepublik Deutschland Let |
Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
|
JP3534417B2
(ja)
|
1997-03-10 |
2004-06-07 |
ロシュ ダイアグノスティックス ゲーエムベーハー |
Hiv抗原及びhiv抗体の同時決定方法
|
US6111087A
(en)
|
1997-03-14 |
2000-08-29 |
Transgene S.A. |
Expression of a foamy virus envelope protein
|
JP3954151B2
(ja)
|
1997-03-14 |
2007-08-08 |
トランスジエヌ・エス・アー |
フォーミーウイルスエンベロープタンパク質の発現
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
US6214540B1
(en)
|
1997-03-26 |
2001-04-10 |
University Of Maryland Biotechnology Institute |
Chemokines that inhibit immunodeficiency virus infection and methods based thereon
|
US6328976B1
(en)
|
1997-04-04 |
2001-12-11 |
Immune Response Corporation |
Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor
|
US6531123B1
(en)
|
1997-05-01 |
2003-03-11 |
Lung-Ji Chang |
Lentiviral vectors
|
US6207455B1
(en)
|
1997-05-01 |
2001-03-27 |
Lung-Ji Chang |
Lentiviral vectors
|
DE19718361A1
(de)
|
1997-05-02 |
1998-11-05 |
Dade Behring Marburg Gmbh |
Immunoassay zur Aviditätsbestimmung von Immunglobulinen
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
US6099847A
(en)
|
1997-05-15 |
2000-08-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric Gag pseudovirions
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
WO1998053048A1
(en)
|
1997-05-21 |
1998-11-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
|
US6372217B1
(en)
|
1997-06-03 |
2002-04-16 |
Regents Of The University Of Minnesota |
Methods for the treatment of CD7+ viral infection with TXU-7-PAP
|
DE19723463A1
(de)
|
1997-06-04 |
1998-12-10 |
Dade Behring Marburg Gmbh |
Immunchemische Bestimmung von multivalenten Analyten
|
US20030138454A1
(en)
|
1997-06-09 |
2003-07-24 |
Oxxon Pharmaccines, Ltd. |
Vaccination method
|
US6070126A
(en)
|
1997-06-13 |
2000-05-30 |
William J. Kokolus |
Immunobiologically-active linear peptides and method of identification
|
US6780598B1
(en)
|
1997-06-13 |
2004-08-24 |
William J. Kokolus |
Method of identifying and locating immunobiologically-active linear peptides
|
US20020136722A1
(en)
|
1997-06-18 |
2002-09-26 |
Heath Andrew William |
Vaccination method
|
US7118742B2
(en)
|
1997-07-07 |
2006-10-10 |
La Jolla Institute For Allergy And Immunology |
Ligand for herpes simplex virus entry mediator and methods of use
|
IS4518A
(is)
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US5891994A
(en)
|
1997-07-11 |
1999-04-06 |
Thymon L.L.C. |
Methods and compositions for impairing multiplication of HIV-1
|
US6855539B2
(en)
|
1997-07-11 |
2005-02-15 |
Pamgene International B.V. |
Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
|
WO1999004011A2
(en)
|
1997-07-18 |
1999-01-28 |
Innogenetics N.V. |
Hiv-1 group o antigens and uses thereof
|
DE19731465A1
(de)
|
1997-07-22 |
1999-01-28 |
Boehringer Mannheim Gmbh |
Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
|
US6153392A
(en)
|
1997-07-30 |
2000-11-28 |
Bionova Corporation |
Devices and methods comprising an HBcAg from hepatitis B virus
|
EP0905516A1
(en)
|
1997-07-31 |
1999-03-31 |
Sumitomo Pharmaceuticals Company, Limited |
Circulation thin layer liquid phase assay
|
DE19733364A1
(de)
|
1997-08-01 |
1999-02-04 |
Koszinowski Ulrich H Prof |
Verfahren zur Klonierung eines großen Virusgenoms
|
WO1999007869A1
(en)
|
1997-08-05 |
1999-02-18 |
University Of Florida |
Live recombinant vaccine comprising inefficiently or non-replicating virus
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6019979A
(en)
|
1997-08-15 |
2000-02-01 |
The Picower Institute For Medical Research |
Anti-viral treatment with pertussis toxin B oligomer
|
WO1999009139A1
(en)
|
1997-08-15 |
1999-02-25 |
Rubicon Laboratory, Inc. |
Retrovirus and viral vectors
|
ATE317432T1
(de)
|
1997-08-19 |
2006-02-15 |
Idera Pharmaceuticals Inc |
Hiv-spezifische oligonukleotide und verfahren zu deren verwendung
|
ATE435661T1
(de)
|
1997-08-29 |
2009-07-15 |
Antigenics Inc |
Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel
|
US6815201B2
(en)
|
1997-09-08 |
2004-11-09 |
The Public Health Research Institute Of The City Of New York, Inc. |
HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies
|
WO1999012416A1
(en)
|
1997-09-09 |
1999-03-18 |
The Trustees Of Columbia University In The City Of New York |
T-independent conjugate-vaccines
|
GB9719357D0
(en)
|
1997-09-11 |
1997-11-12 |
Ortho Clinical Diagnostics |
Immunoassay Utilizing Two Incubations With Labelled Antigen
|
AU9399498A
(en)
|
1997-09-18 |
1999-04-05 |
Trustees Of The University Of Pennsylvania, The |
Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
|
NZ503586A
(en)
|
1997-09-25 |
2002-03-28 |
Upjohn Co |
Thioalkyl alpha substituted pyrimidine compounds for treating HIV.
|
EP1029918A4
(en)
|
1997-09-26 |
2003-01-02 |
Kyowa Hakko Kogyo Kk |
HIV-RECOGNIZING T-KILLER T-LYMPHOCYTE RECEPTOR
|
US6368604B1
(en)
|
1997-09-26 |
2002-04-09 |
University Of Maryland Biotechnology Institute |
Non-pyrogenic derivatives of lipid A
|
US6716429B1
(en)
|
1997-10-01 |
2004-04-06 |
Dana-Farber Cancer Institute, Inc. |
Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
AU1449499A
(en)
|
1997-10-31 |
1999-05-24 |
Maxygen, Incorporated |
Modification of virus tropism and host range by viral genome shuffling
|
US6908617B1
(en)
|
1997-11-10 |
2005-06-21 |
Dana-Farber Cancer Institute, Inc. |
Glycosylated modified primate lentivirus envelope polypeptides
|
WO1999024464A1
(en)
|
1997-11-10 |
1999-05-20 |
Dana-Farber Cancer Institute, Inc |
Glycosylated modified primate lentivirus envelope polypeptides
|
US5972339A
(en)
|
1997-11-13 |
1999-10-26 |
The General Hospital Corporation |
Method of eliciting anti-HIV-1 helper T cell responses
|
FR2771011B1
(fr)
|
1997-11-17 |
2000-01-28 |
Hippocampe |
Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
CA2310805A1
(en)
|
1997-11-24 |
1999-06-03 |
Johnson T. Wong |
Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
|
US6391635B1
(en)
|
1997-11-24 |
2002-05-21 |
Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
US6610833B1
(en)
|
1997-11-24 |
2003-08-26 |
The Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
US6911315B2
(en)
|
1997-11-24 |
2005-06-28 |
David L. Rimm |
Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
|
EP0922958B1
(de)
|
1997-12-11 |
2002-10-02 |
Roche Diagnostics GmbH |
Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
|
US6569418B1
(en)
|
1997-12-11 |
2003-05-27 |
University Of Maryland Biotechnology Institute |
Immuno-modulating effects of chemokines in DNA vaccination
|
US6270956B1
(en)
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
EP1042001B1
(en)
|
1997-12-16 |
2002-04-03 |
Chiron Corporation |
Use of microparticles combined with submicron oil-in-water emulsions
|
US6060256A
(en)
|
1997-12-16 |
2000-05-09 |
Kimberly-Clark Worldwide, Inc. |
Optical diffraction biosensor
|
DE19756975A1
(de)
|
1997-12-20 |
1999-06-24 |
Hoechst Marion Roussel De Gmbh |
Bindungspartner für Inhibitoren von cyclinabhängigen Kinasen und ihre Verwendung zur Suche nach Inhibitoren, zur Diagnose oder zur Therapie einer Erkrankung
|
FR2773156B1
(fr)
|
1997-12-26 |
2000-03-31 |
Biovacs Inc |
Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
|
US6803231B1
(en)
|
1998-01-30 |
2004-10-12 |
Vanderbilt University |
Method of delivering antigens for vaccination with a live vector
|
US6602709B1
(en)
|
1998-02-20 |
2003-08-05 |
The Rockefeller University |
Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
|
US6284194B1
(en)
|
1998-03-11 |
2001-09-04 |
Albert E. Chu |
Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
|
JP2002508940A
(ja)
|
1998-03-13 |
2002-03-26 |
デイナ−ファーバー キャンサー インスティチュート,インコーポレイテッド |
ヒト化抗体およびその使用
|
US6303081B1
(en)
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6403092B1
(en)
|
1998-04-01 |
2002-06-11 |
Duke University |
Immune response modulator alpha-2 macroglobulin complex
|
WO1999051754A1
(en)
|
1998-04-02 |
1999-10-14 |
Dana-Farber Cancer Institute, Inc. |
Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
|
US7157083B2
(en)
|
1998-04-17 |
2007-01-02 |
Surrogate Pharmaceutical Pathways, Llc |
Compositions and methods for treating retroviral infections
|
US6919318B1
(en)
|
1998-04-22 |
2005-07-19 |
Chiron Corporation |
Enhancing immune responses to genetic immunization by using a chemokine
|
FR2777909B1
(fr)
|
1998-04-24 |
2002-08-02 |
Pasteur Institut |
Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
|
AU760669B2
(en)
|
1998-04-28 |
2003-05-22 |
Galenica Pharmaceuticals, Inc. |
Polysaccharide-antigen conjugates
|
ES2180241T3
(es)
|
1998-05-06 |
2003-02-01 |
Roche Diagnostics Gmbh |
Eliminacion de interferencias causadas por factores reumaticos.
|
EP1078105B1
(en)
|
1998-05-12 |
2004-11-24 |
Genecure LLC |
Replication defective hiv vaccine
|
WO1999058658A2
(en)
|
1998-05-13 |
1999-11-18 |
Epimmune, Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
AU3988799A
(en)
|
1998-05-13 |
1999-11-29 |
Genetix Pharmaceuticals, Inc. |
Novel lentiviral packaging cells
|
EP1079862B1
(en)
|
1998-05-20 |
2010-07-07 |
Immunomedics, Inc. |
Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
|
WO1999060110A2
(en)
|
1998-05-20 |
1999-11-25 |
The University Of Tennessee Research Corporation |
Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
|
US6322969B1
(en)
|
1998-05-27 |
2001-11-27 |
The Regents Of The University Of California |
Method for preparing permuted, chimeric nucleic acid libraries
|
US6555342B1
(en)
|
1998-06-03 |
2003-04-29 |
Uab Research Foundation |
Fusion protein delivery system and uses thereof
|
US6706729B1
(en)
|
1998-06-19 |
2004-03-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thiolesters and uses thereof
|
AP1717A
(en)
|
1998-06-19 |
2007-01-30 |
Vertex Pharma |
Sulfonamide inhibitors of aspartyl protease.
|
TWI229679B
(en)
|
1998-06-20 |
2005-03-21 |
United Biomedical Inc |
Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
|
US6803187B1
(en)
|
1998-06-24 |
2004-10-12 |
Innogenetics N.V. |
Method for detection of drug-selected mutations in the HIV protease gene
|
JP2002518452A
(ja)
|
1998-06-24 |
2002-06-25 |
エモリ ユニバーシティ |
Hivの治療薬物の製造のための他の抗hiv薬と組み合わせた3’−アジド−2’,3’−ジデオキシウリジンの使用
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
AU5036899A
(en)
|
1998-06-26 |
2000-01-17 |
Aventis Pasteur |
Use of poxviruses as enhancer of specific immunity
|
FR2781676B1
(fr)
|
1998-07-31 |
2004-04-02 |
Pasteur Merieux Serums Vacc |
Trimere du produit d'expression du gene env de hiv
|
WO2000009075A2
(en)
|
1998-08-14 |
2000-02-24 |
Galenica Pharmaceuticals, Inc. |
Chemically modified saponins and the use thereof as adjuvants
|
US6203974B1
(en)
|
1998-09-03 |
2001-03-20 |
Abbott Laboratories |
Chemiluminescent immunoassay for detection of antibodies to various viruses
|
US6558961B1
(en)
|
1998-09-04 |
2003-05-06 |
Powderject Research Limited |
Immunodiagnostics using particle delivery methods
|
US6475718B2
(en)
|
1998-09-08 |
2002-11-05 |
Schering Aktiengesellschaft |
Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
EP1001021B1
(en)
|
1998-09-25 |
2003-08-27 |
Wolfgang Prodinger |
Monoclonal antibody to human CD21, and its uses
|
US6596477B1
(en)
|
1998-09-28 |
2003-07-22 |
University Of Maryland Biotechnology Institute |
Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A
|
US6448078B1
(en)
|
1998-10-09 |
2002-09-10 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle
|
US6562800B1
(en)
|
1998-10-30 |
2003-05-13 |
University Of Southern California |
Use of immunopotentiating sequences for inducing immune response
|
US6407077B1
(en)
|
1998-11-05 |
2002-06-18 |
Emory University |
β-L nucleosides for the treatment of HIV infection
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
US6027731A
(en)
|
1998-11-17 |
2000-02-22 |
Wisconsin Alumni Research Foundation |
Pertussis toxin induced lymphocytosis
|
DE19856463B4
(de)
|
1998-11-26 |
2006-02-02 |
Heinrich-Pette-Institut |
Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren
|
US6589763B1
(en)
|
1998-11-26 |
2003-07-08 |
Heinrich-Pette-Institute |
Retroviral hybrid vectors pseudotyped with LCMV
|
GB9826069D0
(en)
|
1998-11-28 |
1999-01-20 |
Univ Leeds |
HIV vaccine
|
US6221579B1
(en)
|
1998-12-11 |
2001-04-24 |
Kimberly-Clark Worldwide, Inc. |
Patterned binding of functionalized microspheres for optical diffraction-based biosensors
|
US6579673B2
(en)
|
1998-12-17 |
2003-06-17 |
Kimberly-Clark Worldwide, Inc. |
Patterned deposition of antibody binding protein for optical diffraction-based biosensors
|
US6017537A
(en)
|
1998-12-18 |
2000-01-25 |
Connaught Laboratories, Inc. |
Formyl methionyl peptide vaccine adjuvant
|
EP1141728B1
(en)
|
1998-12-21 |
2007-10-17 |
Monash University |
Kidney disease detection and treatment
|
US6337181B1
(en)
|
1998-12-21 |
2002-01-08 |
Jeffrey Joseph Stewart |
Method of specifying vaccine components for viral quasispecies
|
ATE411286T1
(de)
|
1998-12-25 |
2008-10-15 |
Shionogi & Co |
Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften
|
JP2002533124A
(ja)
|
1998-12-31 |
2002-10-08 |
カイロン コーポレイション |
Hivポリペプチドの改善された発現およびウイルス様粒子の生成
|
US6423544B1
(en)
|
1998-12-31 |
2002-07-23 |
Chiron Corporation |
Compositions and methods for producing recombinant virions
|
US6790657B1
(en)
|
1999-01-07 |
2004-09-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Lentivirus vector system
|
EP1150985B1
(en)
|
1999-01-19 |
2004-06-30 |
Robert C. Leif |
A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes
|
US6900010B2
(en)
|
1999-01-25 |
2005-05-31 |
Musc Foundation For Research Development |
Compositions and methods for detecting human immunodeficiency virus
|
US6410013B1
(en)
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
DE19920704C1
(de)
|
1999-01-26 |
2000-08-31 |
Technologie Integrale Ltd |
Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
|
US6329510B1
(en)
|
1999-01-29 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR1 antibodies and methods of use therefor
|
US6303293B1
(en)
|
1999-02-02 |
2001-10-16 |
Ortho-Clinical Diagnostics, Inc. |
Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
|
US6946465B2
(en)
|
1999-02-02 |
2005-09-20 |
4 Aza Bioscience Nv |
Immunosuppressive effects of pteridine derivatives
|
US6214221B1
(en)
|
1999-02-22 |
2001-04-10 |
Henry B. Kopf |
Method and apparatus for purification of biological substances
|
US7074556B2
(en)
|
1999-03-02 |
2006-07-11 |
Invitrogen Corporation |
cDNA synthesis improvements
|
NO311807B1
(no)
|
1999-03-04 |
2002-01-28 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
|
DE19910044A1
(de)
|
1999-03-08 |
2000-09-14 |
Bodo Plachter |
Virale Partikel, die nach Infektion durch humanes Cytomegalovirus freigesetzt werden und ihre Verwendung als Impfstoff
|
US6596497B1
(en)
|
1999-03-17 |
2003-07-22 |
New York Blood Center, Inc. |
Screening of antiviral compounds targeted to the HIV-1 gp41 core structure
|
WO2000029561A2
(en)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
CA2267481A1
(en)
|
1999-03-30 |
2000-09-30 |
Gabriel Pulido-Cejudo |
Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
|
US6773920B1
(en)
|
1999-03-31 |
2004-08-10 |
Invitrogen Corporation |
Delivery of functional protein sequences by translocating polypeptides
|
US6451601B1
(en)
|
1999-04-12 |
2002-09-17 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells for use in gene therapy
|
US6358739B1
(en)
|
1999-04-12 |
2002-03-19 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells
|
FR2792206B1
(fr)
|
1999-04-13 |
2006-08-04 |
Centre Nat Rech Scient |
Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1
|
MXPA01011499A
(es)
|
1999-05-13 |
2002-06-04 |
American Cyanamid Co |
Formulaciones de combinacion de adyuvantes.
|
US6420545B1
(en)
|
1999-05-24 |
2002-07-16 |
The Trustees Of The University Of Pennsylvania |
CD4-independent HIV envelope proteins as vaccines and therapeutics
|
US6562571B1
(en)
|
1999-05-25 |
2003-05-13 |
University Of Rochester |
Human heme-regulated initiation factor 2-α kinase
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
US6730297B1
(en)
|
1999-05-28 |
2004-05-04 |
Chiron Corporation |
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
|
US6884785B2
(en)
|
1999-06-17 |
2005-04-26 |
The Scripps Research Institute |
Compositions and methods for the treatment or prevention of autoimmune diabetes
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
FR2798385B1
(fr)
|
1999-06-21 |
2003-09-05 |
Bio Merieux |
Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2
|
WO2001003681A2
(en)
|
1999-07-08 |
2001-01-18 |
Prendergast Patrick T |
Use of flavones, coumarins and related compounds to treat infections
|
EP1196772A2
(en)
|
1999-07-08 |
2002-04-17 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
JP3536731B2
(ja)
|
1999-07-28 |
2004-06-14 |
富士レビオ株式会社 |
HIV−1p24抗原の免疫測定方法及び試薬
|
JP2003511362A
(ja)
|
1999-10-04 |
2003-03-25 |
ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュー ジャージー |
新規カルバメートおよび尿素類
|
US7311920B1
(en)
|
1999-10-08 |
2007-12-25 |
University Of Maryland Biotechnology Institute |
Virus coat protein/receptor chimeras and methods of use
|
US6908612B2
(en)
|
1999-10-08 |
2005-06-21 |
University Of Maryland Biotechnology Institute |
Virus coat protein/receptor chimeras and methods of use
|
EP1221968B1
(en)
|
1999-10-13 |
2010-01-13 |
Novartis Vaccines and Diagnostics, Inc. |
Method of obtaining cellular immune responses from proteins
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
WO2001026608A2
(en)
|
1999-10-14 |
2001-04-19 |
Ledbetter Jeffrey A |
Dna vaccines encoding antigen linked to a domain that binds cd40
|
MXPA02004148A
(es)
|
1999-10-26 |
2003-08-20 |
Int Aids Vaccine Initiative |
Vectores bacterianos invasivos para expresar replicones de alfavirus.
|
AU1241901A
(en)
|
1999-11-24 |
2001-06-04 |
Biotronics Technologies, Inc. |
Devices and methods for detecting analytes using electrosensor having capture reagent
|
GB9927629D0
(en)
|
1999-11-24 |
2000-01-19 |
Croda Int Plc |
Compounds
|
KR100354562B1
(ko)
|
1999-12-06 |
2002-09-30 |
주식회사 제넥신 |
원숭이에서 SIVmac239의 감염에 대한 방어를유도하는 AIDS DNA 백신
|
WO2001042507A1
(en)
|
1999-12-09 |
2001-06-14 |
Advanced Research & Technology Institute |
Fluorescent in situ rt-pcr
|
US6399295B1
(en)
|
1999-12-17 |
2002-06-04 |
Kimberly-Clark Worldwide, Inc. |
Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors
|
US6656706B2
(en)
|
1999-12-23 |
2003-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
|
CA2396384A1
(en)
|
2000-01-14 |
2001-07-19 |
Whitehead Institute For Biomedical Research |
In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
|
ATE305801T1
(de)
|
2000-01-20 |
2005-10-15 |
Univ Zuerich Inst Fuer Medizin |
Intratumorale verabreichung nackter il-12 codierender nukleinsäuremoleküle
|
US6242461B1
(en)
|
2000-01-25 |
2001-06-05 |
Pfizer Inc. |
Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
|
US6692745B2
(en)
|
2000-01-28 |
2004-02-17 |
Arogenics Pharmaceuticals, Inc. |
Compositions and methods for inhibition of HIV-1 infection
|
US6316205B1
(en)
|
2000-01-28 |
2001-11-13 |
Genelabs Diagnostics Pte Ltd. |
Assay devices and methods of analyte detection
|
JP2003522948A
(ja)
|
2000-02-10 |
2003-07-29 |
パナコス ファーマシューティカルズ, インコーポレイテッド |
ウイルス融合インヒビターの検出のための分析
|
US6312931B1
(en)
|
2000-02-11 |
2001-11-06 |
Purepulse Technologies, Inc. |
Protecting molecules in biologically derived compositions while treating with high intensity broad-spectrum pulsed light
|
DE60112050T2
(de)
|
2000-03-02 |
2006-04-27 |
Polymun Scientific Immunbiologische Forschung Gmbh |
Rekombinantes influenza a virus
|
US6821955B2
(en)
|
2000-04-07 |
2004-11-23 |
Baylor College Of Medicine |
Macroaggregated protein conjugates as oral genetic immunization delivery agents
|
US6699722B2
(en)
|
2000-04-14 |
2004-03-02 |
A-Fem Medical Corporation |
Positive detection lateral-flow apparatus and method for small and large analytes
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
US6399067B1
(en)
|
2000-04-28 |
2002-06-04 |
Thymon L.L.C. |
Methods and compositions for impairing multiplication of HIV-1
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
EP1156112B1
(en)
|
2000-05-18 |
2006-03-01 |
Geneart GmbH |
Synthetic gagpol genes and their uses
|
NZ522755A
(en)
|
2000-05-19 |
2004-05-28 |
Corixa Corp |
Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds being administered in absence of exogenous antigen
|
US6544780B1
(en)
|
2000-06-02 |
2003-04-08 |
Genphar, Inc. |
Adenovirus vector with multiple expression cassettes
|
EP1290231A4
(en)
|
2000-06-06 |
2004-06-30 |
Univ Columbia |
TWO HYBRID ANALYSIS THAT DETECTS DIMERIZATION OF HIV-1 REVERSE TRANSCRIPTASE
|
JP2004507231A
(ja)
|
2000-06-15 |
2004-03-11 |
アメリカ合衆国 |
免疫応答を向上させるための、gm−csfを発現する組換え非−複製性ウィルスおよびその使用
|
US6551828B1
(en)
|
2000-06-28 |
2003-04-22 |
Protemation, Inc. |
Compositions and methods for generating expression vectors through site-specific recombination
|
US7407663B2
(en)
|
2000-06-29 |
2008-08-05 |
Lipid Sciences, Inc. |
Modified immunodeficiency virus particles
|
US7439052B2
(en)
|
2000-06-29 |
2008-10-21 |
Lipid Sciences |
Method of making modified immunodeficiency virus particles
|
ATE321063T1
(de)
|
2000-08-04 |
2006-04-15 |
Corixa Corp |
Neue immunoeffectorverbindungen
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
US6582920B2
(en)
|
2000-09-01 |
2003-06-24 |
Gen-Probe Incorporated |
Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
|
NO314587B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
BR0114094A
(pt)
|
2000-09-22 |
2003-07-22 |
Univ Duke |
Imunógeno
|
US7033593B2
(en)
|
2000-09-22 |
2006-04-25 |
Duke University |
Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
|
WO2002026212A2
(en)
|
2000-09-28 |
2002-04-04 |
Chiron Corporation |
Microparticle compositions and methods for the manufacture thereof
|
AU2002212996A1
(en)
|
2000-09-28 |
2002-04-08 |
Non-Invasive Monitoring Systems, Inc. |
External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention
|
US7419829B2
(en)
|
2000-10-06 |
2008-09-02 |
Oxford Biomedica (Uk) Limited |
Vector system
|
US6528325B1
(en)
|
2000-10-13 |
2003-03-04 |
Dexall Biomedical Labs, Inc. |
Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays
|
US7122180B2
(en)
|
2000-10-23 |
2006-10-17 |
Children's Medical Center Corporation |
DNA vectors containing mutated HIV proviruses
|
WO2002034951A2
(en)
|
2000-10-23 |
2002-05-02 |
Gen-Probe Incorporated |
Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
|
DE10053781B4
(de)
|
2000-10-30 |
2008-07-03 |
Geneart Ag |
Kernexportreportersystem
|
US6689877B2
(en)
|
2000-11-06 |
2004-02-10 |
The Board Of Regents Of The University Of Nebraska |
Methods and compositions for the treatment of human immunodeficiency virus infection
|
US6800281B2
(en)
|
2000-11-09 |
2004-10-05 |
Oxford Biomedica (Uk) Limited |
Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases
|
US7083787B2
(en)
|
2000-11-15 |
2006-08-01 |
Globeimmune, Inc. |
Yeast-dendritic cell vaccines and uses thereof
|
US7097842B2
(en)
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
DE60116371T3
(de)
|
2000-11-23 |
2016-11-17 |
Bavarian Nordic A/S |
Variante des modifizierten vaccinia ankara virus
|
US6818392B2
(en)
|
2000-12-06 |
2004-11-16 |
Abbott Laboratories |
Monoclonal antibodies to human immunodeficiency virus and uses thereof
|
US6712612B1
(en)
|
2000-12-12 |
2004-03-30 |
Genecure Llc |
Safe and stable retroviral helper cell line and related compositions and methods
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
US6887977B1
(en)
|
2000-12-28 |
2005-05-03 |
Children's Hospital, Inc. |
Methods and materials relating to CD8-tropic HIV-1
|
KR100912741B1
(ko)
|
2001-01-10 |
2009-08-18 |
아막사 아게 |
모듈식 트랜스펙션 시스템
|
US6768004B2
(en)
|
2001-01-11 |
2004-07-27 |
Mueller Sybille |
Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1F7, an anti-idiotypic antibody reactive with anti-HIV antibodies
|
WO2002062296A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Chemocentryx, Inc. |
Methods and compositions useful for stimulating an immune response
|
US7301010B2
(en)
|
2001-02-15 |
2007-11-27 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating HIV infection with cupredoxin and cytochrome c
|
WO2002066629A2
(en)
|
2001-02-21 |
2002-08-29 |
Gabriele Hahn |
Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
|
CA2439067C
(en)
|
2001-03-13 |
2011-02-15 |
Novartis Ag |
Lentiviral packaging constructs
|
CA2441626A1
(en)
|
2001-03-28 |
2002-10-17 |
Children's Medical Center Corporation |
Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo
|
US7060273B2
(en)
|
2001-04-06 |
2006-06-13 |
Progenics Pharmaceuticals, Inc. |
Methods for inhibiting HIV-1 infection
|
JP4866535B2
(ja)
|
2001-05-11 |
2012-02-01 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
動物で用いるに適した免疫調節用デバイス
|
GB0112324D0
(en)
|
2001-05-21 |
2001-07-11 |
Croda Int Plc |
Compounds
|
FR2825372B1
(fr)
|
2001-06-01 |
2004-06-18 |
Centre Nat Rech Scient |
Pseudotypage des vecteurs vih-1 par des enveloppes de rhabdovirus
|
US6469083B1
(en)
|
2001-06-04 |
2002-10-22 |
Ferro Corporation |
No dry master batch for polyester resins
|
US7270997B2
(en)
|
2001-06-12 |
2007-09-18 |
Ramsingh Arlene I |
Coxsackievirus B4 expression vectors and uses thereof
|
JP4262594B2
(ja)
|
2001-06-22 |
2009-05-13 |
エフ.ホフマン−ラ ロシュ アーゲー |
レトロウイルス表面糖タンパク質を含む可溶性複合体
|
US6962982B2
(en)
|
2001-06-22 |
2005-11-08 |
Roche Diagnostics Corporation |
Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
|
JP2005515162A
(ja)
|
2001-07-02 |
2005-05-26 |
ファイザー・プロダクツ・インク |
マイコプラズマ・ハイオニューモニエ(Mycoplasmahyopneumoniae)を用いた単回ワクチン接種
|
EP1411770A4
(en)
|
2001-07-05 |
2006-05-10 |
Chiron Corp |
POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
|
US6997863B2
(en)
|
2001-07-25 |
2006-02-14 |
Triton Biosystems, Inc. |
Thermotherapy via targeted delivery of nanoscale magnetic particles
|
EP1420818B1
(en)
|
2001-07-26 |
2018-11-21 |
Otago Innovation Limited |
Antigenic compositions
|
EP1283272B1
(en)
|
2001-08-08 |
2013-11-13 |
Janssen R&D Ireland |
Methods and means for assessing HIV envelope inhibitor therapy
|
US6958211B2
(en)
|
2001-08-08 |
2005-10-25 |
Tibotech Bvba |
Methods of assessing HIV integrase inhibitor therapy
|
US7008650B2
(en)
|
2001-08-09 |
2006-03-07 |
Lam Paul Y S |
Compositions for the treatment of acquired immunodeficiency disease
|
AU2002331599A1
(en)
|
2001-08-16 |
2003-03-03 |
The General Hospital Corporation |
Epitopes of human immunodeficiency virus-1
|
AU2002331408B2
(en)
|
2001-08-20 |
2008-05-08 |
Proteome Systems Ltd |
Diagnostic testing process and apparatus
|
US20030170614A1
(en)
|
2001-08-31 |
2003-09-11 |
Megede Jan Zur |
Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
|
GB0122232D0
(en)
|
2001-09-14 |
2001-11-07 |
Medical Res Council |
Gene expression
|
EP1427826B1
(en)
|
2001-09-20 |
2011-04-20 |
Glaxo Group Limited |
HIV- RT-nef-Gag codon optimised DNA vaccines
|
ES2268095T3
(es)
|
2001-10-16 |
2007-03-16 |
Endo Pharmaceuticals Inc. |
Uso de carbinoles para el tratamiento de la disfuncion neuropatica.
|
AU2002337885B1
(en)
|
2001-10-16 |
2003-04-28 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Broadly cross-reactive neutralizing antibodies against human ummunodeficiency virus selected by Env-CD4-co-receptor complexes
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US7172761B2
(en)
|
2001-11-07 |
2007-02-06 |
Duke University |
Polyvalent immunogen
|
US7153509B2
(en)
|
2001-11-07 |
2006-12-26 |
Duke University |
Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope
|
US7195768B2
(en)
|
2001-11-07 |
2007-03-27 |
Duke University |
Polyvalent immunogen
|
US20030118568A1
(en)
*
|
2001-12-18 |
2003-06-26 |
Board Of Trustees Of The University Of Arkansas |
Viral stealth technology to prevent T cell-mediated rejection of xenografts
|
US6525028B1
(en)
|
2002-02-04 |
2003-02-25 |
Corixa Corporation |
Immunoeffector compounds
|
US7030094B2
(en)
|
2002-02-04 |
2006-04-18 |
Corixa Corporation |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
|
FR2836146B1
(fr)
|
2002-02-15 |
2005-01-07 |
Urrma R & D |
IMMUNOGLOBULINE IgG3 MARQUEUR DE PROTECTION CONTRE LES MALADIES VIRALES INFECTIEUSES ET SES UTILISATIONS
|
US7211240B2
(en)
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
US6927031B2
(en)
|
2002-04-12 |
2005-08-09 |
Rigel Pharmaceuticals, Incorporated |
Methods for identifying polypeptide factors interacting with RNA
|
AU2002307776A1
(en)
|
2002-04-16 |
2003-10-27 |
Kamada Ltd. |
Ultrapure transferrin for pharmaceutical compositions
|
EP1501369B1
(en)
|
2002-04-26 |
2015-06-24 |
Genentech, Inc. |
Non-affinity purification of proteins
|
EP1497412A4
(en)
|
2002-04-30 |
2006-11-22 |
Avior Therapeutics Inc |
ADENOVIRUS VECTORS FOR IMMUNOTHERAPY
|
US7223368B2
(en)
|
2002-05-03 |
2007-05-29 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US7223534B2
(en)
|
2002-05-03 |
2007-05-29 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US7118855B2
(en)
|
2002-05-03 |
2006-10-10 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US7214530B2
(en)
|
2002-05-03 |
2007-05-08 |
Kimberly-Clark Worldwide, Inc. |
Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
|
US7056519B2
(en)
|
2002-05-17 |
2006-06-06 |
Aventis Pasteur S.A. |
Methods for inducing HIV-neutralizing antibodies
|
FR2839646B1
(fr)
|
2002-05-17 |
2008-04-11 |
Bioalliance Pharma |
Utilisation de derives de quinoleine a effet anti-integrase et ses applications
|
US7091049B2
(en)
|
2002-06-26 |
2006-08-15 |
Kimberly-Clark Worldwide, Inc. |
Enhanced diffraction-based biosensor devices
|
DE10232322A1
(de)
|
2002-07-16 |
2004-07-29 |
Hahn, Gabriele, Dr. |
Viral kodierte CxC determinieren den Gewebetropismus von HCMV
|
US6933377B2
(en)
|
2002-07-29 |
2005-08-23 |
Qun Chen |
Compositions comprising multiple immunodeficiency virus subunits for inducing an immune response
|
US7179645B2
(en)
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US7169550B2
(en)
|
2002-09-26 |
2007-01-30 |
Kimberly-Clark Worldwide, Inc. |
Diffraction-based diagnostic devices
|
US6919077B2
(en)
|
2002-09-27 |
2005-07-19 |
Aids Research, Llc |
LFA-1 alpha subunit antibodies and methods of use
|
US6821744B2
(en)
|
2002-10-29 |
2004-11-23 |
Roche Diagnostics Operations, Inc. |
Method, assay, and kit for quantifying HIV protease inhibitors
|
WO2004045582A1
(en)
|
2002-11-21 |
2004-06-03 |
Pevion Biotech Ltd. |
High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
|
EP1454981A1
(en)
|
2003-03-03 |
2004-09-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Infectious pestivirus pseudo-particles containing functional erns, E1, E2 envelope proteins
|
US7508781B2
(en)
|
2003-03-25 |
2009-03-24 |
Texas Instruments Incorporated |
Power saving mechanism for wireless LANs via schedule information vector
|
EP2359851A3
(en)
|
2003-03-28 |
2011-08-31 |
The Government of the United States of America, represented by The Secretary, Department of Health and Human Services |
MVA expressing modified hiv envelope, gag, and pol genes
|
EP1629003B1
(en)
|
2003-05-23 |
2008-03-12 |
Oregon Health & Science University |
Methods for identifying inhibitors
|
CN100475846C
(zh)
|
2003-06-10 |
2009-04-08 |
Ns基因公司 |
增加的神经胚素分泌
|
US7457973B2
(en)
|
2003-06-20 |
2008-11-25 |
Texas Instruments Incorporated |
System and method for prioritizing data transmission and transmitting scheduled wake-up times to network stations based on downlink transmission duration
|
WO2005012545A2
(en)
|
2003-07-25 |
2005-02-10 |
The Regents Of The University Of California |
Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors
|
PT1651260E
(pt)
|
2003-07-25 |
2009-09-24 |
Boehringer Ingelheim Vetmed |
Lawsonia intracellularis de origem europeia e vacinas, agentes de diagnóstico e métodos para sua utilização
|
FR2860237B1
(fr)
|
2003-09-30 |
2006-03-10 |
Centre Nat Rech Scient |
Polypeptide d'interaction comprenant un motif heptapeptidique et un domaine de penetration cellulaire
|
US7611829B2
(en)
|
2004-01-30 |
2009-11-03 |
Fujifilm Corporation |
Silver halide color photographic light-sensitive material and color image-forming method
|
EP1740602A2
(en)
|
2004-04-09 |
2007-01-10 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
|
AU2005285513B2
(en)
|
2004-05-25 |
2011-02-24 |
Oregon Health And Science University |
SIV and HIV vaccination using RhCMV- and HCMV-based vaccine vectors
|
EP1602676A1
(en)
|
2004-06-01 |
2005-12-07 |
SOLVAY (Société Anonyme) |
Catalytic compositions
|
US20080044384A1
(en)
|
2004-06-25 |
2008-02-21 |
Medlmmune Vaccines, Inc. |
Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens
|
ATE526420T1
(de)
|
2004-08-03 |
2011-10-15 |
Univ Syracuse |
Schalter aus verzweigten oder mehrkettigen nukleinsäuren zum messen oder screenen von liganden
|
JP2006190869A
(ja)
|
2005-01-07 |
2006-07-20 |
Nec Electronics Corp |
半導体装置の設計方法および信頼性評価方法
|
CA2598547C
(en)
|
2005-02-21 |
2016-01-19 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Primate t-lymphotropic viruses
|
US7189522B2
(en)
|
2005-03-11 |
2007-03-13 |
Chembio Diagnostic Systems, Inc. |
Dual path immunoassay device
|
WO2006125983A1
(en)
|
2005-05-23 |
2006-11-30 |
Oxxon Therapeutics Ltd |
Compositions for inducing an immune response against hepatitis b
|
US7892729B1
(en)
|
2005-06-23 |
2011-02-22 |
Iowa State University Research Foundation, Inc. |
Universal and differential serologic assay for swine influenza virus
|
WO2007027860A2
(en)
|
2005-08-31 |
2007-03-08 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
US7879914B2
(en)
|
2005-09-23 |
2011-02-01 |
Pathlogica LLC |
Methods for treating viral infections using polyamine analogs
|
US7585675B2
(en)
|
2005-11-15 |
2009-09-08 |
University Of Kansas Medical Center |
Inhibition of HIV and SHIV replication with antisense interleukin-4
|
US7886962B2
(en)
|
2006-08-17 |
2011-02-15 |
Verizon Patent And Licensing Inc. |
Multi-function transaction device
|
US7748618B2
(en)
|
2006-08-21 |
2010-07-06 |
Verizon Patent And Licensing Inc. |
Secure near field transaction
|
US20100142823A1
(en)
|
2007-03-07 |
2010-06-10 |
Ze Wang |
2d partially parallel imaging with k-space surrounding neighbors based data reconstruction
|
BRPI0814060A2
(pt)
|
2007-07-06 |
2015-01-06 |
Trubion Pharmaceuticals Inc |
Peptídeos ligantes tendo um domínio de ligação específico disposto em c-terminal
|
SI2215117T2
(en)
|
2007-10-30 |
2018-04-30 |
Genentech, Inc. |
Purification of the antibody by cation exchange chromatography
|
JP2012519484A
(ja)
|
2009-03-06 |
2012-08-30 |
マウント・シナイ・スクール・オヴ・メディシン |
マイクロrna応答要素を含む弱毒化生インフルエンザウイルスワクチン
|
SG181901A1
(en)
|
2009-12-23 |
2012-08-30 |
4Antibody Ag |
Binding members for human cytomegalovirus
|
US20120289760A1
(en)
|
2010-01-27 |
2012-11-15 |
Hill Ann B |
Cytomegalovirus-based immunogenic preparations
|
EP2550362B1
(en)
*
|
2010-03-25 |
2017-01-04 |
Oregon Health&Science University |
Cmv glycoproteins and recombinant vectors
|
SG10201503450WA
(en)
*
|
2010-05-05 |
2015-06-29 |
Thirion Christian |
Vaccine against beta-herpesvirus infection and use thereof
|
EP3351636B1
(en)
*
|
2010-05-14 |
2020-07-01 |
Oregon Health & Science University |
Recombinant hcmv and rhcmv vectors encoding a heterologous antigen isolated from a paramyxoviridae virus and uses thereof
|
CA2832109C
(en)
|
2011-06-10 |
2021-07-06 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
US20130156808A1
(en)
|
2011-11-22 |
2013-06-20 |
Stipan Jonjic |
Vaccine comprising beta-herpesvirus
|
US9783823B2
(en)
|
2013-03-05 |
2017-10-10 |
Oregon Health & Science University |
Cytomegalovirus vectors enabling control of T cell targeting
|
SG11201700315YA
(en)
|
2014-07-16 |
2017-02-27 |
Univ Oregon Health & Science |
Human cytomegalovirus comprising exogenous antigens
|
EP3048114A1
(en)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus antigens and uses thereof
|
EP3256595A4
(en)
|
2015-02-10 |
2018-09-26 |
Oregon Health & Science University |
Methods and compositions useful in generating non canonical cd8+ t cell responses
|
MA43285A
(fr)
|
2015-11-20 |
2018-09-26 |
Univ Oregon Health & Science |
Vecteurs cmv comprenant des éléments de reconnaissance des microarn
|
CA3028827A1
(en)
|
2016-06-22 |
2017-12-28 |
Aeras |
Recombinant cytomegalovirus vectors as vaccines for tuberculosis
|
EP3475446A1
(en)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
CA3040303A1
(en)
|
2016-10-18 |
2018-04-26 |
Oregon Health & Science University |
Cytomegalovirus vectors eliciting t cells restricted by major histocompatibility complex e molecules
|